<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension‐type headache in adults - Banzi, R - 2015 | Cochrane Library</title> <meta content="Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension‐type headache in adults - Banzi, R - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011681/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension‐type headache in adults - Banzi, R - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011681/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011681" name="dc.identifier" scheme="DOI"/> <meta content="Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension‐type headache in adults" name="citation_title"/> <meta content="Rita Banzi" name="citation_author"/> <meta content="IRCCS ‐ Mario Negri Institute for Pharmacological Research" name="citation_author_institution"/> <meta content="rita.banzi@marionegri.it" name="citation_author_email"/> <meta content="Cristina Cusi" name="citation_author"/> <meta content="Istituti Clinici di Perfezionamento" name="citation_author_institution"/> <meta content="Concetta Randazzo" name="citation_author"/> <meta content="University of Bologna" name="citation_author_institution"/> <meta content="Roberto Sterzi" name="citation_author"/> <meta content="Azienda Ospedaliera Niguarda" name="citation_author_institution"/> <meta content="Dario Tedesco" name="citation_author"/> <meta content="University of Bologna" name="citation_author_institution"/> <meta content="Lorenzo Moja" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD011681" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/05/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011681/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011681/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011681/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Adrenergic Uptake Inhibitors [*therapeutic use]; Citalopram [therapeutic use]; Cyclohexanols [therapeutic use]; Fluoxetine [therapeutic use]; Fluvoxamine [therapeutic use]; Norepinephrine [*metabolism]; Paroxetine [therapeutic use]; Randomized Controlled Trials as Topic; Sertraline [therapeutic use]; Tension‐Type Headache [*prevention &amp; control]; Venlafaxine Hydrochloride" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011681&amp;doi=10.1002/14651858.CD011681&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="WbpyPs9C";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011681\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011681\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011681\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011681\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","hr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011681",title:"Selective serotonin reuptake inhibitors (SSRIs) and serotonin\\u2010norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension\\u2010type headache in adults",firstPublishedDate:"May 1, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WbpyPs9C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011681&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011681';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011681/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011681/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011681%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011681/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011681/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011681/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011681/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011681" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011681/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011681" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011681/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011681/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>8528 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011681" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-sec-0098"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-sec-0054"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-sec-0093"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011681/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/appendices#CD011681-sec-0103"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/table_n/CD011681StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/table_n/CD011681StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011681/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011681/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011681/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011681/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011681/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension‐type headache in adults </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011681/information#CD011681-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Rita Banzi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011681/information#CD011681-cr-0003">Cristina Cusi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011681/information#CD011681-cr-0004">Concetta Randazzo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011681/information#CD011681-cr-0005">Roberto Sterzi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011681/information#CD011681-cr-0006">Dario Tedesco</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011681/information#CD011681-cr-0007">Lorenzo Moja</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011681/information/en#CD011681-sec-0108">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 May 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011681/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011681">https://doi.org/10.1002/14651858.CD011681</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011681-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011681-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011681-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011681-abs-0002">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011681-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011681-abs-0001" lang="en"> <section id="CD011681-sec-0001"> <h3 class="title" id="CD011681-sec-0001">Background</h3> <p>This is an updated version of the Cochrane review published in 2005 on selective serotonin re‐uptake inhibitors (SSRIs) for preventing migraine and tension‐type headache. The original review has been split in two parts and this review now only regards tension‐type headache prevention. Another updated review covers migraine. Tension‐type headache is the second most common disorder worldwide and has high social and economic relevance. As serotonin and other neurotransmitters may have a role in pain mechanisms, SSRIs and serotonin‐norepinephrine reuptake inhibitors (SNRIs) have been evaluated for the prevention of tension‐type headache. </p> </section> <section id="CD011681-sec-0002"> <h3 class="title" id="CD011681-sec-0002">Objectives</h3> <p>To determine the efficacy and tolerability of SSRIs and SNRIs compared to placebo and other active interventions in the prevention of episodic and chronic tension‐type headache in adults. </p> </section> <section id="CD011681-sec-0003"> <h3 class="title" id="CD011681-sec-0003">Search methods</h3> <p>For the original review, we searched the Cochrane Central Register of Controlled Trials (CENTRAL 2003, Issue 4), MEDLINE (1966 to January 2004), EMBASE (1994 to May 2003), and <i>Headache Quarterly</i> (1990 to 2003). For this update, we revised the original search strategy to reflect the broader type of intervention (SSRIs and SNRIs). We searched CENTRAL (2014, Issue 10) on the Cochrane Library, MEDLINE (1946 to November 2014), EMBASE (1980 to November 2014), and PsycINFO (1987 to November 2014). We also checked the reference lists of retrieved articles and searched trial registries for ongoing trials. </p> </section> <section id="CD011681-sec-0004"> <h3 class="title" id="CD011681-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials comparing SSRIs or SNRIs with any type of control intervention in participants 18 years and older, of either sex, with tension‐type headache. </p> </section> <section id="CD011681-sec-0005"> <h3 class="title" id="CD011681-sec-0005">Data collection and analysis</h3> <p>Two authors independently extracted data (headache frequency, index, intensity, and duration; use of symptomatic/analgesic medication; quality of life; and withdrawals) and assessed the risk of bias of trials. The primary outcome is tension‐type headache frequency, measured by the number of headache attacks or the number of days with headache per evaluation period. </p> </section> <section id="CD011681-sec-0006"> <h3 class="title" id="CD011681-sec-0006">Main results</h3> <p>The original review included six studies on tension‐type headache. We now include eight studies with a total of 412 participants with chronic forms of tension‐type headache. These studies evaluated five SSRIs (citalopram, sertraline, fluoxetine, paroxetine, fluvoxamine) and one SNRI (venlafaxine). The two new studies included in this update are placebo controlled trials, one evaluated sertraline and one venlafaxine. Six studies, already included in the previous version of this review, compared SSRIs to other antidepressants (amitriptyline, desipramine, sulpiride, mianserin). Most of the included studies had methodological and/or reporting shortcomings and lacked adequate power. Follow‐up ranged between two and four months. </p> <p>Six studies explored the effect of SSRIs or SNRIs on tension‐type headache frequency, the primary endpoint. At eight weeks of follow‐up, we found no difference when compared to placebo (two studies, N = 127; mean difference (MD) ‐0.96, 95% confidence interval (CI) ‐3.95 to 2.03; I<sup>2</sup>= 0%) or amitriptyline (two studies, N = 152; MD 0.76, 95% CI ‐2.05 to 3.57; I<sup>2</sup>= 44%). </p> <p>When considering secondary outcomes, SSRIs reduce the symptomatic/analgesic medication use for acute headache attacks compared to placebo (two studies, N = 118; MD ‐1.87, 95% CI ‐2.09 to ‐1.65; I<sup>2</sup>= 0%). However, amitriptyline appeared to reduce the intake of analgesic more efficiently than SSRIs (MD 4.98, 95% CI 1.12 to 8.84; I<sup>2</sup>= 0%). The studies supporting these findings were considered at unclear risk of bias. We found no differences compared to placebo or other antidepressants in headache duration and intensity. </p> <p>SSRIs or SNRI were generally more tolerable than tricyclics. However, the two groups did not differ in terms of number of participants who withdrew due to adverse events or for other reasons (four studies, N = 257; odds ratio (OR) 1.04; 95% CI 0.41 to 2.60; I<sup>2</sup>= 25% and OR 1.55, 95% CI 0.71 to 3.38; I<sup>2</sup>= 0%). </p> <p>We did not find any study comparing SSRIs or SNRIs with pharmacological treatments other than antidepressants (e.g. botulinum toxin) or non‐drug therapies (e.g. psycho‐behavioural treatments, manual therapy, acupuncture). </p> </section> <section id="CD011681-sec-0007"> <h3 class="title" id="CD011681-sec-0007">Authors' conclusions</h3> <p>Since the last version of this review, the new included studies have not added high quality evidence to support the use of SSRIs or venlafaxine (a SNRI) as preventive drugs for tension‐type headache. Over two months of treatment, SSRIs or venlafaxine are no more effective than placebo or amitriptyline in reducing headache frequency in patients with chronic tension‐type headache. SSRIs seem to be less effective than tricyclic antidepressants in terms of intake of analgesic medications. Tricyclic antidepressants are associated with more adverse events; however, this did not cause a greater number of withdrawals. No reliable information is available at longer follow‐up. Our conclusion is that the use of SSRIs and venlafaxine for the prevention of chronic tension‐type headache is not supported by evidence. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011681-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011681-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011681-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011681-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011681-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011681-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011681-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011681-abs-0004" lang="en"> <h3>Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for preventing tension‐type headache </h3> <p>Tension‐type headache is a common type of headache that can significantly impair people's quality of life. Individuals who experience frequent or severe headaches may benefit from medications taken before the pain starts. Two classes of medication, the selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs), typically used to treat depression, are evaluated in this review. </p> <p>This is an update of a previous review that included studies on migraine and tension‐type headache. The original review has been split into two separate reviews: this update addresses only studies on tension‐type headache, while a second focuses on migraine. When we updated this review (November 2014), we identified two new studies. Six studies were already included in the previous version of the review. Overall, we analysed a total of 412 adults participants. All the studies had a small number of participants and were conducted over a period of two to four months. Only a few were of high quality. </p> <p>Results suggest that SSRIs or SNRIs are no better than placebo (sugar pill) in reducing the number of days with tension‐type headache. There were no differences in minor side effects between participants treated with SSRIs or SNRIs versus those treated with placebo. SSRIs and SNRIs do not seem to offer advantages when compared to other active treatments, specifically the tricyclic antidepressant, amitriptyline. The participants treated with SSRIs or SNRIs suffered fewer minor side effects than those who took amitriptyline, however the number of people who stopped taking one drug or the other due to side effects was approximately equal. These results are based on poor quality, small, short‐term trials (no more than four months). We did not find a study comparing SSRIs or SNRIs with other medications (e.g. botulinum toxin) or non‐drug therapies (e.g. psycho‐behavioural treatments, manual therapy, acupuncture). </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011681-sec-0098" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011681-sec-0098"></div> <h3 class="title" id="CD011681-sec-0099">Implications for practice</h3> <section id="CD011681-sec-0099"> <p>Since the last version of this review, we included two new relevant studies which have provided little new evidence on the effectiveness of SSRIs and SNRIs in patients with tension‐type headache. The usefulness of SSRIs and SNRIs to prevent headache attacks is unclear and it is likely that these drugs do not represent an efficacious option for the prevention of chronic tension‐type headache, the population in which pharmacological prophylaxis is more appropriate. We did not find information on the use of these drugs in the prevention of episodic tension‐type headache. Considering the most relevant outcomes (headache frequency, intensity and duration) these new antidepressants did not show a superiority over placebo, and seem to be less efficacious than tricyclic antidepressants, particularly amitriptyline, in terms of duration of the headache and use of symptomatic medications.There is some evidence that SSRIs are better tolerated than other antidepressants with respect to minor adverse events, however, this does not impact on the total number of dropouts. </p> <p>We cannot draw any conclusions on the place in therapy of antidepressants with respect to other non‐pharmacological prophylactic treatments, or other preventive drug classes, for the prevention of tension‐type headache in adults. </p> </section> <h3 class="title" id="CD011681-sec-0100">Implications for research</h3> <section id="CD011681-sec-0100"> <p>Overall, the standard in terms of design and reporting still needs to be improved, as does the protection against random error. For example, open design is unacceptable in this context. Headache frequency should be the primary efficacy measure in any new trial (<a href="./references#CD011681-bbs2-0032" title="BendtsenL , BigalME , CerboR , DienerHC , HolroydK , LamplC , et al. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in tension‐type headache: Second edition. Cephalalgia2009;30(1):1–16. ">Bendtsen 2009</a>). Because tension‐type headache is often a chronic condition, longer follow‐up and harder outcomes that relate to real life (headache frequency, acute headache medication, days off work and quality of life) should be assessed (<a href="./references#CD011681-bbs2-0032" title="BendtsenL , BigalME , CerboR , DienerHC , HolroydK , LamplC , et al. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in tension‐type headache: Second edition. Cephalalgia2009;30(1):1–16. ">Bendtsen 2009</a>). This will also avoid the use of non‐validated indexes, discouraging multiple comparisons at different time points, with the warning that multiple data testing easily results in misleading statistically significant findings that appear by chance (<a href="./references#CD011681-bbs2-0066" title="MojaPL , CusiC , SterziRR , CanepariC . Selective serotonin re‐uptake inhibitors (SSRIs) for preventing migraine and tension‐type headaches. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD002919.pub2] ">Moja 2005</a>; <a href="./references#CD011681-bbs2-0060" title="ThornleyB , AdamsC . Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ1998;317(7167):1181‐4. ">Thornley 1998</a>). Standardised collection of outcomes as suggested by the COMET (Core Outcome Measures in Effectiveness Trials) Initiative, which is engaged in developing, applying and promoting core outcomes sets (COS), using rigorous consensus methods, for effectiveness trials (<a href="./references#CD011681-bbs2-0063" title="WilliamsonPR , AltmanDG , BlazebyJM , ClarkeM , DevaneD , GargonE , et al. Developing core outcome sets for clinical trials: issues to consider. Trials2012;13:132. ">Williamson 2012</a>) could be helpful. The sample size should be carefully estimated on the basis of the available evidence and the expected effect, in order to protect the study against random error. Amitriptyline should be considered a reference comparator in terms of efficacy in clinical trials comparing antidepressants for patients with chronic headache disorders, however the value of new studies comparing different antidepressants in this setting is questionable. </p> <p>During the current update, we noticed a clear reduction in the number of publications testing SSRIs and SNRIs in the prophylaxis of tension‐type headache. Other preventive strategies, especially non‐drug treatments, are likely to be the target of future research. For several clinically relevant outcomes, we reported a low level of evidence. This indicates that “further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate”. However, we think that a small, or large, RCT comparing a SSRI or a SNRI versus another drug or another non‐pharmacological intervention is not a priority and might not exert a significant impact on the overall evidence. In the field of antidepressants, it might be of greater interest exploring the efficacy and safety of drugs belonging to different classes (e.g. mirtazapine) and focus on depressed patients with tension‐type headache, as optimal treatments and the role of weak antidepressants are still debatable. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011681-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011681-sec-0022"></div> <div class="table" id="CD011681-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">SSRIs or SNRIs versus placebo for tension‐type headache</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SSRIs or SNRIs compared to placebo for tension‐type headache</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with tension‐type headache<br/> <b>Intervention:</b> SSRIs or SNRIs<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SSRIs or SNRIs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache frequency</b><br/> (number of days with headache) </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache frequency ranged across control groups from<br/> <b>13.8 to 21.7 days with headache</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache frequency in the intervention groups was<br/> <b>0.96 lower</b><br/> (3.95 lower to 2.03 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>127<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> l<b>ow<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache intensity</b><br/> (score) </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache severity in the control groups was<br/> <b>3.9</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache severity in the intervention groups was<br/> <b>0.30 lower</b><br/> (1.13 lower to 0.53 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache duration</b><br/> (hours) </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache duration in the control groups was<br/> <b>6.57</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache duration in the intervention groups was<br/> <b>0.07 lower</b><br/> (2.69 lower to 2.55 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic/analgesic medication for acute headache attacks</b> <br/> (doses/month) </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean symptomatic/analgesic medication for acute headache attacks ranged across control groups from<br/> <b>1.07 to 34.8 doses</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean symptomatic/analgesic medication for acute headache attacks in the intervention groups was<br/> <b>1.87 lower</b><br/> (2.09 to 1.65 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This finding is largely driven by the results reported by a study at high risk of sponsorship bias </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache index</b> </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache index ranged across control groups from<br/> <b>18.3 to 877</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache index in the intervention groups was <b>0.24 SDs lower</b><br/> (0.59 lower to 0.11 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>128<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>As a rule of thumb, 0.2 SDs represents a small difference, 0.5 moderate and 0.8 large (<a href="./references#CD011681-bbs2-0034" title="CohenJ . Statistical Power Analysis in the Behavioral Sciences. 2nd Edition. New Jersey: Hillsdale: Lawrence Erlbaum Associates, Inc, 1988. ">Cohen 1988</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>OR 3.72</b> <br/> (0.79 to 17.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>190<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b><br/> (9 to 163) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI</b> : Confidence interval; <b>OR</b> : Odds ratio; <b>SD</b> : Standard deviation; <b>SNRI</b> : Serotonin‐norepinephrine reuptake inhibitor; <b>SSRI</b>: selective serotonin reuptake inhibitor </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Limitations in study design, imprecision (insufficient data).<br/> <sup>2</sup> Limitations in study design, imprecision (insufficient data), indirectness (lack of generalisability).<br/> <sup>3</sup> Limitations in study design, imprecision (insufficient data), inconsistency (heterogeneity). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011681-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">SSRIs or SNRIs versus other antidepressants for tension‐type headache</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SSRIs or SNRIs compared to other antidepressants for tension‐type headache</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with tension‐type headache<br/> <b>Intervention:</b> SSRIs or SNRIs<br/> <b>Comparison:</b> other antidepressants </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Other antidepressants</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SSRIs or SNRIs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache frequency</b> <br/> (number of days with headache) </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache frequency ranged across control groups from<br/> 14<b>.4 to 18.6 days with headache</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache frequency in the intervention groups was<br/> 0.76<b>higher</b><br/> (2.05 lower to 3.57 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two additional studies (<a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>) evaluated this outcome but were not pooled due to the lack of quantitative data </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache intensity</b><br/> (mean score) </p> <p>Follow‐up: 2 to 4 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache severity score ranged across control groups from<br/> 3.0<b>to 3.8</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache severity score in the intervention groups was<br/> <b>0.32 higher</b><br/> (0.55 lower to 1.19 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Four additional studies (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>; <a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>) evaluated this outcome but were not pooled due to the lack of quantitative data </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache duration</b> <br/> (hours) </p> <p>Follow‐up: 2 to 4 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache duration ranged across control groups from<br/> <b>5.39 to 6.5</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache duration in the intervention groups was<br/> 1<b>.26 higher</b><br/> (0.06 lower to 2.45 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>low<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic/analgesic medication for acute headache attacks</b> <br/> (doses/4 weeks) </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean symptomatic/analgesic medication for acute headache attacks ranged across control groups from<br/> <b>18.9 to 25.3 doses</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean symptomatic/analgesic medication for acute headache attacks in the intervention groups was<br/> <b>4.98 higher</b><br/> (1.12 lower to 8.84 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two additional studies (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>) evaluated this outcome but were not pooled due to the lack of quantitative data </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache index</b> </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache index ranged across control groups from<br/> <b>11.4 to 616</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache index in the intervention groups was<br/> <b>0.42 SDs higher</b><br/> (0 to 0.85 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>As a rule of thumb, 0.2 SDs represents a small difference, 0.5 moderate and 0.8 large (<a href="./references#CD011681-bbs2-0034" title="CohenJ . Statistical Power Analysis in the Behavioral Sciences. 2nd Edition. New Jersey: Hillsdale: Lawrence Erlbaum Associates, Inc, 1988. ">Cohen 1988</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One study (<a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>) reported qualitative results on this outcome </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>OR 1.04</b> <br/> (0.41 to 2.60) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>257<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>88 per 1000</b><br/> (37 to 194) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio; <b>SD</b> : Standard deviation; <b>SNRI</b> : Serotonin‐norepinephrine reuptake inhibitor; <b>SSRI</b>: selective serotonin reuptake inhibitor </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Limitations in study design, imprecision (insufficient data), inconsistency (heterogeneity).<br/> <sup>2</sup> Limitations in study design, imprecision (insufficient data).<br/> <sup>3</sup> Limitations in study design, imprecision (insufficient data), indirectness (lack of generalisability). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011681-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011681-sec-0023"></div> <p>This updated systematic review considers the evidence for the efficacy and tolerability of selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension‐type headache. It is an update of a systematic review on SSRIs for the prevention of migraine and tension‐type headache previously published in the Cochrane Database of Systematic Reviews (<a href="./references#CD011681-bbs2-0065" title="CusiC , SterziR , CanepariC . Selective serotonin re‐uptake inhibitors (SSRIs) for preventing migraine and tension‐type headaches. Cochrane Database of Systematic Reviews2001, Issue 1. [DOI: 10.1002/14651858.CD002919] ">Cusi 2001</a>; <a href="./references#CD011681-bbs2-0066" title="MojaPL , CusiC , SterziRR , CanepariC . Selective serotonin re‐uptake inhibitors (SSRIs) for preventing migraine and tension‐type headaches. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD002919.pub2] ">Moja 2005</a>). This original review has been split into two separate reviews: this update addresses only studies on tension‐type headache, while a second focuses on migraine prevention (<a href="./references#CD011681-bbs2-0031" title="BanziR , CusiC , RandazzoC , SterziR , TedescoD , MojaL . Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults. Cochrane Database of Systematic Reviews2015, Issue 4. [DOI: 10.1002/14651858.CD002919.pub3] ">Banzi 2015</a>). </p> <section id="CD011681-sec-0024"> <h3 class="title" id="CD011681-sec-0024">Description of the condition</h3> <p>Tension‐type headache is the most common type of primary headache in the general population. Its lifetime prevalence estimates vary widely, ranging from 30% to 78% (<a href="./references#CD011681-bbs2-0042" title="Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia2013;33(9):629‐808. ">IHS 2013</a>). The Global Burden of Disease Survey 2010 ranked it as the second most prevalent disorder (<a href="./references#CD011681-bbs2-0062" title="VosT , FlaxmanAD , NaghaviM , LozanoR , MichaudC , EzzatiM , et al. Years lived with disability (YLD) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet2012;380(9859):2163–96. ">Vos 2012</a>). Although typically less disabling than migraine, tension‐type headache has significant impact when it occurs frequently, given the high prevalence in the general population. </p> <p>Tension‐type headache is typically bilateral, pressing or tightening in quality, and of mild to moderate intensity, lasting hours or days, and it is characterised by an increased pericranial tenderness recorded by manual palpation. According to the attack frequency, tension‐type headache can be classified as episodic or chronic. Episodic tension‐type headache is subdivided into an infrequent subform (less than one day of headache per month) and a frequent subform (one to 14 days of headache per month), the latter being associated with considerable disability. The prevalence of episodic tension‐type headache peaks in the fourth decade of life, with women having a higher prevalence than men (<a href="./references#CD011681-bbs2-0056" title="SchwartzBS , StewartWF , SimonD , LiptonRB . Epidemiology of tension‐type headache. JAMA1998;279(5):381‐3. ">Schwartz 1998</a>). Chronic forms evolve from frequent episodic tension‐type headache, often in relation to medication overuse and occurs more than 15 days per month on average for more than three months, causing greatly decreased quality of life and high disability (<a href="./references#CD011681-bbs2-0042" title="Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia2013;33(9):629‐808. ">IHS 2013</a>). The prevalence of chronic tension‐type headache (more than 15 days per month) is approximately 2% to 3% (<a href="./references#CD011681-bbs2-0053" title="RasmussenBK . Epidemiology of headache. Cephalgia2001;21(7):774‐7. ">Rasmussen 2001</a>; <a href="./references#CD011681-bbs2-0056" title="SchwartzBS , StewartWF , SimonD , LiptonRB . Epidemiology of tension‐type headache. JAMA1998;279(5):381‐3. ">Schwartz 1998</a>). </p> <p>Tension‐type headache is very often associated with disability and high personal and socioeconomic costs. Some estimations reported that the disability attributable to chronic forms is larger than that due to migraine (<a href="./references#CD011681-bbs2-0059" title="StovnerLJ , HagenK , JensenR , KatsaravaZ , LiptonR , ScherA , et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia2007;27(3):193‐210. ">Stovner 2007</a>). Costs of the disease for patients and healthcare systems are also an issue, although lower than those due to migraine. A recent cost‐of‐illness survey conducted as part of the Eurolight project in six European countries reported an annual direct and indirect cost of tension‐type headache per person of EUR 303, and a total annual cost for the European countries of EUR 21 billion for adults aged 18 to 65 years (<a href="./references#CD011681-bbs2-0046" title="LindeM , GustavssonA , StovnerLJ , SteinerTJ , BarréJ , KatsaravaZ , et al. The cost of headache disorders in Europe: the Eurolight project. European Journal of Neurology2012;19(5):703‐11. ">Linde 2012</a>). </p> <p>For many years tension‐type headache was considered to be primarily psychogenic. More recent studies suggested a neurobiological basis, at least for the more severe subtypes. The exact mechanisms are not known. Peripheral pain mechanisms like the hyperexcitability of peripheral afferent neurons of the head and neck muscles are most likely to play a role in episodic tension‐type headache, whereas central pain mechanisms and generalised increased pain sensitivity are involved in the chronic forms (<a href="./references#CD011681-bbs2-0030" title="AshinaM . Neurobiology of chronic tension‐type headache. Cephalalgia2004;24:161‐72. ">Ashina 2004</a>;<a href="./references#CD011681-bbs2-0042" title="Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia2013;33(9):629‐808. ">IHS 2013</a>; <a href="./references#CD011681-bbs2-0047" title="LoderE , RizzoliP . Tension‐type headache. BMJ2008;336:88‐92. ">Loder 2008</a>). Susceptibility to tension‐type headache is influenced by genetic factors (<a href="./references#CD011681-bbs2-0055" title="RussellMB , Saltyte‐BenthJ , LeviN . Are infrequent episodic, frequent episodic and chronic tension‐type headache inherited?. Journal of Headache Pain2006;7:119‐26. ">Russell 2006</a>). </p> </section> <section id="CD011681-sec-0025"> <h3 class="title" id="CD011681-sec-0025">Description of the intervention</h3> <p>In general, acute (symptomatic) medications are used in the episodic tension‐type headache, whereas prophylactic drugs should be considered in the frequent episodic and chronic forms (<a href="./references#CD011681-bbs2-0041" title="Headache Classification Subcommittee of the International Headache Society (IHS). The International Classification of Headache Disorders, 2nd edition. Cephalalgia2004;24(Suppl 1):9‐160. ">IHS 2004</a>). We were not able to retrieve clear data on the use of preventive therapy in people with tension‐type headache. All major categories of preventive pharmacologic therapies for tension‐type headache were initially developed for other medical indications. Progress in the understanding of tension‐type headache pathophysiology and the clinical observation of the analgesic effect of some antidepressants (<a href="./references#CD011681-bbs2-0044" title="KantorTG . The pharmacological control of musculoskeletal pain. Canadian Journal of Physiology and Pharmacology1991;69(5):713‐8. ">Kantor 1991</a>; <a href="./references#CD011681-bbs2-0048" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>; <a href="./references#CD011681-bbs2-0057" title="SindrupSH , JensenTS . Pharmacologic treatment of pain in polyneuropathy. Neurology2000;55(7):915‐20. ">Sindrup 2000</a>) led to exploring the potential benefits of SSRIs and SNRIs, a class of compounds typically used as antidepressants in the treatment of depression, anxiety disorders, and some personality disorders. SSRIs are believed to increase the extracellular level of the neurotransmitters such as serotonin by inhibiting its reuptake into the presynaptic cell. Depending on their chemical structure, these compounds have varying degrees of selectivity for the other monoamine transporters, with pure SSRIs having only weak affinity for the noradrenaline transporter and non‐selective compounds also blocking the reuptake of noradrenaline and dopamine (<a href="./references#CD011681-bbs2-0052" title="PreskornSH , RossR , StangaCY . Selective serotonin reuptake inhibitors. In: PreskornSH , FeighnerHP , StangaCY , RossR editor(s). Antidepressants: Past, Present and Future. Berlin: Springer, 2004. ">Preskorn 2004</a>). </p> </section> <section id="CD011681-sec-0026"> <h3 class="title" id="CD011681-sec-0026">How the intervention might work</h3> <p>Preventive treatment is especially well suited to patients with very frequent or severe headaches. It encompasses mainly chronic tension‐type headache, causing significant headache‐related disability, and resistance to acute therapy (<a href="./references#CD011681-bbs2-0042" title="Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia2013;33(9):629‐808. ">IHS 2013</a>). For patients with frequent headaches, those who respond insufficiently to acute therapies, or those who overuse acute medication, preventive therapies may be indicated (<a href="./references#CD011681-bbs2-0058" title="SmithermanTA , WaltersB , MaizelsM , PenzienDB . The use of antidepressants for headache prophylaxis. CNS Neuroscience and Therapeutics2011;17:462–9. ">Smitherman 2011</a>). Proposed pharmacological options for prophylaxis of tension‐type headache include Angiotensin‐converting Enzyme (ACE) inhibitors and angiotensin II receptor blockers, antidepressants, beta blockers or antiepileptics. Non‐pharmacological approaches include acupuncture, manual therapies and psychological therapies, exercise and education, and self management (<a href="./references#CD011681-bbs2-0050" title="National Institute of Health and Care Excellence. Headaches: diagnosis and management of headaches in young people and adults. Clinical guidelines, CG150September 2012:187‐214. ">NICE 2012</a>). </p> <p>Preventive treatments aim to eliminate headache pain without intolerable harms and they are also expected to reduce use of acute drugs and improve quality of life. In clinical practice the choice of a drug, or of one non‐pharmacological approach over another, is based on many drug‐related factors such as familiarity, efficacy, and adverse effects, as well as many patient characteristics such as headache frequency. </p> </section> <section id="CD011681-sec-0027"> <h3 class="title" id="CD011681-sec-0027">Why it is important to do this review</h3> <p>In general, the use of pharmacological preventive strategies for tension‐type headache is controversial (<a href="./references#CD011681-bbs2-0050" title="National Institute of Health and Care Excellence. Headaches: diagnosis and management of headaches in young people and adults. Clinical guidelines, CG150September 2012:187‐214. ">NICE 2012</a>). Although the evidence supporting antidepressants as prophylactic agents is based on sporadic observation in clinical practice and small clinical trials, some guidelines such as those from the European Federation of Neurological Societies recommend amitriptyline as drug of first choice, while mirtazapine and venlafaxine are to be considered as drugs of second choice (<a href="./references#CD011681-bbs2-0033" title="BendtsenL , EversS , LindeM , MitsikostasDD , SandriniG , SchoenenJ . EFNS guideline on the treatment of tension‐type headache ‐ Report of an EFNS task force. European Journal of Neurology2010;17:1318–25. ">Bendtsen 2010</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011681-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011681-sec-0028"></div> <p>To determine the efficacy and tolerability of SSRIs and SNRIs compared to placebo and other active interventions in the prevention of episodic and chronic tension‐type headache. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011681-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011681-sec-0029"></div> <section id="CD011681-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011681-sec-0031"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) of SSRIs or SNRIs taken regularly to prevent the occurrence of tension‐type headache attacks, or to reduce the severity of those attacks, or both. We included published and unpublished trials in any language provided that enough information about eligibility was available. </p> </section> <section id="CD011681-sec-0032"> <h4 class="title">Types of participants</h4> <p>Participants of either sex, aged 18 and older who had been diagnosed with chronic tension‐type headache or episodic forms, whenever prophylaxis was considered appropriate. Headache diagnoses were based on the diagnostic criteria of the International Headache Society (IHS) (<a href="./references#CD011681-bbs2-0042" title="Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia2013;33(9):629‐808. ">IHS 2013</a> and its previous editions <a href="./references#CD011681-bbs2-0041" title="Headache Classification Subcommittee of the International Headache Society (IHS). The International Classification of Headache Disorders, 2nd edition. Cephalalgia2004;24(Suppl 1):9‐160. ">IHS 2004</a>; <a href="./references#CD011681-bbs2-0040" title="Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia1988;8(Suppl 7):1‐96. ">IHS 1988</a>) and the Ad Hoc Committee on the Classification of Headache (<a href="./references#CD011681-bbs2-0028" title="Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA1962;179(9):717‐8. ">Ad Hoc 1962</a>). Where no such criteria were specified, the diagnosis of tension‐type headache had to be based on at least some of its distinctive features (e.g. bilateral location, pressing/tightening (non‐pulsating) quality, mild or moderate intensity, not aggravated by routine physical activity such as walking or climbing stairs). Frequent episodic tension‐type headache is defined if 10 episodes occur more than one but less than 15 days per month for at least three months. Chronic headache is defined when occurring at least 15 days/month (180 days/year), for at least a three‐month period. </p> <p>We included studies in which participants were described as having 'combination' or 'mixed' tension‐type headache and migraine, only if data on tension‐type headache participants could be extracted. We excluded trials including patients with a secondary headache. </p> </section> <section id="CD011681-sec-0033"> <h4 class="title">Types of interventions</h4> <p>To be considered for inclusion, trials were required to have at least one treatment arm in which patients were treated with one of the SSRIs or SNRIs commercially available or under development (fluoxetine, paroxetine, fluvoxamine, citalopram, escitalopram, milnacipram, sertraline, venlafaxine, desvenlafaxine, duloxetine, dapoxetine). We considered any dosage or any dosing regimen lasting for at least four weeks. Acceptable comparator groups included placebo, no intervention, other drug treatments, and behavioural or physical therapies. It was expected that patients were free to take medication for acute headache attacks as needed during the trial period. </p> </section> <section id="CD011681-sec-0034"> <h4 class="title">Types of outcome measures</h4> <p>In this update, we reconsidered the outcome measures, taking into consideration patients' preferences, scientific rigour, and the availability of data. In line with the guidelines for controlled trials of drugs in tension‐type headache issued by the IHS (<a href="./references#CD011681-bbs2-0032" title="BendtsenL , BigalME , CerboR , DienerHC , HolroydK , LamplC , et al. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in tension‐type headache: Second edition. Cephalalgia2009;30(1):1–16. ">Bendtsen 2009</a>), we considered the following main outcomes. </p> <section id="CD011681-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011681-list-0001"> <li> <p>Headache frequency.</p> </li> </ul> </p> <p>We considered the following ways of measuring headache frequency, listed in the preferred order: </p> <p> <ul id="CD011681-list-0002"> <li> <p>number of attacks per evaluation period;</p> </li> <li> <p>number of days with tension‐type headache; and</p> </li> <li> <p>responders, i.e. patients with ≥ 50% reduction in headache frequency.</p> </li> </ul> </p> </section> <section id="CD011681-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011681-list-0003"> <li> <p>Headache intensity, measured using numerical or verbal scale.</p> </li> <li> <p>Headache duration (hours).</p> </li> <li> <p>Symptomatic/analgesic medication use for acute headache attacks.</p> </li> <li> <p>Headache index: we preferred those measures that incorporated frequency as a component (along with intensity, or duration, or both), but considered other types of indexes when these were not available. The formula used to calculate the headache index is recorded in the text below and in the table describing the <a href="./references#CD011681-sec-0115" title="">Characteristics of included studies</a> whenever it was reported by investigators. </p> </li> <li> <p>Quality of life, measured using validated instruments.</p> </li> <li> <p>Withdrawals from treatment (for any reason and due to adverse events).</p> </li> <li> <p>Minor adverse events.</p> </li> </ul> </p> <p>We sought headache‐associated symptoms (nausea, photophobia, phonophobia) and other outcome measures (e.g. workdays lost, mood improvement, and cost‐effectiveness). </p> <p>We initially recorded the outcomes for all the assessment periods reported, then, once all the data had been collected, decided upon which time points to consider in the analysis; we preferred the last periods of the follow‐up, usually eight and 12 weeks. The analyses considered only outcomes obtained directly from the patient, excluding those judged by the treating physician or study personnel. </p> <p>We included the following outcome measures in <a href="./full#CD011681-tbl-0001">summary of findings Table for the main comparison</a> and <a href="./full#CD011681-tbl-0002">summary of findings Table 2</a>. </p> <p> <ol id="CD011681-list-0004"> <li> <p>Headache frequency.</p> </li> <li> <p>Headache intensity.</p> </li> <li> <p>Headache duration.</p> </li> <li> <p>Symptomatic/analgesic medication use for acute headache attacks.</p> </li> <li> <p>Headache index.</p> </li> <li> <p>Quality of life.</p> </li> <li> <p>Withdrawals due to adverse events.</p> </li> </ol> </p> </section> </section> </section> <section id="CD011681-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <p>The search strategies used for this review are common to a review on SSRIs and SNRIs for migraine prophylaxis in adults (<a href="./references#CD011681-bbs2-0031" title="BanziR , CusiC , RandazzoC , SterziR , TedescoD , MojaL . Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults. Cochrane Database of Systematic Reviews2015, Issue 4. [DOI: 10.1002/14651858.CD002919.pub3] ">Banzi 2015</a>). </p> <section id="CD011681-sec-0038"> <h4 class="title">Electronic searches</h4> <p>For the original review, we searched the Cochrane Central Register of Controlled Trials (CENTRAL 2003, Issue 4), MEDLINE (1966 to January 2004), EMBASE (1994 to May 2003), , and<i>Headache Quarterly</i> (1990 to 2003). For this update, we applied a revised search strategy to reflect the broader type of intervention (SSRIs and SNRIs). </p> <p>We searched:</p> <p> <ul id="CD011681-list-0005"> <li> <p>CENTRAL (Issue 10 of 12, 2014) on the Cochrane Library;</p> </li> <li> <p>MEDLINE (1946 to week 1, November 2014) via OVID;</p> </li> <li> <p>EMBASE (1980 to November 18th 2014),via OVID; and</p> </li> <li> <p>PsycINFO (1987 to week 2November 2014) via OVID.</p> </li> </ul> </p> <p>Details of search strategies are provided in <a href="./appendices#CD011681-sec-0104">Appendix 1</a>. </p> </section> <section id="CD011681-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We also searched trial registries (the metaRegister of controlled trials (mRCT) (<a href="http://www.controlled-trials.com/mrct" target="_blank">www.controlled‐trials.com/mrct</a>), <a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a> and the WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>) for ongoing trials (November 2014). Additional strategies for identifying trials included searching the reference lists of review articles and included studies, searching books related to headache, consulting experts in the field of headache, contacting the authors of trial reports, and contacting pharmaceutical companies to identify additional published or unpublished data. </p> </section> </section> <section id="CD011681-sec-0040"> <h3 class="title" id="CD011681-sec-0040">Data collection and analysis</h3> <p>Compared to the previous version of this review, we revised the assessment of methodological quality of included trials to include the most recent risk of bias approach (<a href="#CD011681-sec-0043">Assessment of risk of bias in included studies</a>). </p> <section id="CD011681-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently screened titles and abstracts from the search and judged whether trials fulfilled the inclusion or exclusion criteria. Disagreements were resolved through discussion with a third author and by contacting the study authors, if needed. Review authors were not blinded to the names of the study authors, their institutions, the journal of publication, or the results. We retrieved all potentially relevant articles for the assessment of the full publication. </p> </section> <section id="CD011681-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently abstracted information on study methods (design, duration, randomisation, blinding, withdrawals), participants (age, sex, type of headache, duration of disease, co‐existing depression and other psychiatric illnesses, and concomitant drugs), interventions (type of drug, route of administration, and dosage), outcomes, and adverse events, using specially designed, pre‐tested electronic extraction forms. We resolved disagreements through discussion with a third review author. We entered data into Review Manager (<a href="./references#CD011681-bbs2-0054" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) for analysis. </p> <p>When outcomes were reported in dichotomous form (success/failure), we required that the threshold for distinguishing between success and failure be clinically significant (for instance, more than a 50% reduction in frequency or severity). </p> <p>When outcome data were reported on an ordinal scale, we selected a threshold based on the definition of clinically significant improvement and converted the data into dichotomous form. If categorical data could not be split into dichotomous outcomes meeting our a priori definition, they were not included in the analysis. </p> <p>When a trial used pre‐ and post‐treatment scores to calculate a change score for each patient and, then, used these within‐patient change scores to calculate a group mean change score, we recorded and analysed the group mean change scores. When only post‐treatment data were available, we used these, relying on allocation to achieve between‐group balance. </p> </section> <section id="CD011681-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors assessed the risk of bias for each of the included studies using the 'Risk of bias' tool developed by The Cochrane Collaboration (<a href="./references#CD011681-bbs2-0037" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. Available at www.cochrane.org. ">Higgins 2011</a>). This includes five domains of bias: selection, performance, attrition, detection and reporting, as well as an ‘other bias’ category to capture other potential threats to validity. </p> <p>Selection bias included an assessment of adequate sequence generation as well as allocation concealment. We assessed sequence generation to be at low risk when studies clearly specified a method for generating a truly random sequence. We assessed allocation concealment to be at low risk if the method used to ensure that investigators enrolling participants could not predict group assignment was described. Performance and detection bias were incorporated under the domain blinding in the 'Risk of bias' tool: we did not consider them separately as the large majority of outcomes were self reported by the patients (i.e. using diaries). We assessed this to be low risk for studies that reported blinding of participants and study personnel. We assessed studies as low risk for attrition bias if an adequate description of participant flow through the study was provided, the proportion of missing outcome data was relatively balanced between groups and the reasons for missing outcome data were provided, relatively balanced across groups and considered unlikely to bias the results. </p> <p>We assessed studies to be at low risk of reporting bias when a published protocol was available and all specified outcomes were included in the study report; we assessed studies without a published protocol as unclear. When an outcome measure was specified and the results were not reported either at baseline or at follow‐up, we considered the study to be at high risk of reporting bias. </p> <p>Other potential threats to validity were assessed, including early trial discontinuation for benefit and trial sponsorship. </p> <p>Review authors were not blinded with respect to study authors, institution, or journal. Disagreements were resolved through discussion with a third author. </p> </section> <section id="CD011681-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>In order to assess efficacy, we extracted raw data for outcomes of interest (means and standard deviations for continuous outcomes and number of events for dichotomous outcomes) where available in the published reports. </p> <p>For dichotomous outcomes, we calculated odds ratios (ORs) along with 95% confidence intervals (CIs). Where outcomes were measured on standard scales, we calculated weighted mean differences (WMDs). Where different scales were used to measure the same or similar outcomes, we calculated standardised mean differences (SMDs). </p> <p>We calculated number needed to treat to benefit, if possible, although this was a rare circumstance due to the large number of statistically insignificant comparisons. We analysed toxicity for total withdrawals due to adverse events. We calculated number needed to treat to harm, if possible. </p> </section> <section id="CD011681-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <section id="CD011681-sec-0046"> <h5 class="title">Cross‐over trials</h5> <p>In randomised cross‐over studies, individuals receive each intervention sequentially in a random order. Cross‐over studies usually contain a washout period, which is a stage after the first treatment, but before the second treatment, where time is given for the active effects of the first treatment to wear off before the new treatment begins (that is, to reduce the carry‐over effect). A concern with the cross‐over design is the risk of a carry‐over effect when the first treatment affects the second. Inadequate washouts are seen when the carry‐over effect exceeds the washout period. For this review, we considered an adequate washout period for cross‐over studies to be a minimum of one week. When including cross‐over studies with no indication about washout or an inadequate period we used only the first arm data. Even though this method does not consider all of the information provided, it avoids inappropriate consideration of correlated information. If results are available split by the particular sequence each participant received or adjusted for period effects and the washout is appropriate, we included the effect estimate and its variability in the meta‐analysis using the generic inverse‐variance method. </p> </section> <section id="CD011681-sec-0047"> <h5 class="title">Cluster trials</h5> <p>We assessed whether the unit of analysis was appropriate for the unit of randomisation. If we were to include cluster‐RCTs, we would use the intra‐class correlation coefficient (ICC) to convert trials to their effective sample size before incorporating them into the meta‐analysis. </p> </section> </section> <section id="CD011681-sec-0048"> <h4 class="title">Dealing with missing data</h4> <p>We described missing data and the dropouts/attrition for each included study in the <a href="./references#CD011681-sec-0115" title="">Characteristics of included studies</a>. We planned the analysis of outcomes on an intention‐to‐treat basis; in other words, we included all of the participants randomised to each group in the analyses, regardless of whether or not they received the allocated intervention, and irrespective of how the original study authors analysed the data. However, because only a few studies reported these data, we analysed the studies according to an "available case" approach. </p> <p>We contacted study authors by email to clarify any missing data. For outcomes reported on a continuous scale, we anticipated that many trials would report pre‐ and post‐treatment group means without reporting data on the variance associated with these means. We attempted to calculate or estimate variances based on primary data or test statistics whenever precise P values or test statistics were provided in sufficient detail. </p> </section> <section id="CD011681-sec-0049"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity by examining the I<sup>2</sup> statistic (<a href="./references#CD011681-bbs2-0035" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. Available at www.cochrane.org. ">Deeks 2011</a>), a quantity that describes the proportion of variation in point estimates that is due to variability across studies, rather than sampling error. </p> <p>We interpreted I<sup>2</sup> as suggested by the latest version of <a href="./references#CD011681-bbs2-0037" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. Available at www.cochrane.org. ">Higgins 2011</a>: </p> <p> <ul id="CD011681-list-0006"> <li> <p>0% to 40%: might not be important;</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity; and</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> <p>In addition, we used a Chi<sup>2</sup> test of homogeneity to determine the strength of evidence that heterogeneity is genuine. </p> <p>We explored clinical variation across studies by comparing the distribution of important participant factors among trials (for example, age) as well as trial factors (randomisation concealment, blinding of outcome assessment, losses to follow‐up, treatment type, and cointerventions). </p> </section> <section id="CD011681-sec-0050"> <h4 class="title">Data synthesis</h4> <p>We performed the analyses using Review Manager (<a href="./references#CD011681-bbs2-0054" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We assumed a considerable clinical heterogeneity and usually combined the studies using the random‐effects model. When including both parallel and cross‐over studies with an adequate washout period, we used the inverse variance method, as recommended by <a href="./references#CD011681-bbs2-0036" title="ElbourneDR , AltmanDG , HigginsJPT , CurtinF , WorthingtonHV , VailA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. ">Elbourne 2002</a>. In the meta‐analysis, the weight of each study is inversely proportional to the variance (one over the square of the standard error) (<a href="./references#CD011681-bbs2-0035" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. Available at www.cochrane.org. ">Deeks 2011</a>). </p> <section id="CD011681-sec-0051"> <h5 class="title">Summary of findings table</h5> <p>We synthesised the main outcome measures (see also ‘<a href="#CD011681-sec-0034">Types of outcome measures</a>’) in two ‘Summary of findings’ tables, comparing SSRIs or SNRIs to placebo (<a href="./full#CD011681-tbl-0001">summary of findings Table for the main comparison</a>) or to other active comparators (<a href="./full#CD011681-tbl-0002">summary of findings Table 2</a>). Whenever possible, we used the control arm to calculate the ‘assumed risk’ values. We assessed the overall quality of evidence for each outcome using the GRADE approach, as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011681-bbs2-0037" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. Available at www.cochrane.org. ">Higgins 2011</a>), against five factors: study design and limitations, consistency of results, directness (generalisability), precision (sufficient data), and reporting of the results across all studies that measure that particular outcome. The quality starts at high when high quality RCTs provide results for the outcome, and reduces by a level for each of the factors not met. </p> <p> <ul id="CD011681-list-0007"> <li> <p>High quality evidence: there are consistent findings among at least 75% of RCTs with no limitations of the study design, consistent, direct and precise data and no known or suspected publication biases. Further research is unlikely to change either the estimate or our confidence in the results. </p> </li> </ul> <ul id="CD011681-list-0008"> <li> <p>Moderate quality evidence: one of the domains is not met. Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> </li> </ul> <ul id="CD011681-list-0009"> <li> <p>Low quality evidence: two of the domains are not met. Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </li> </ul> <ul id="CD011681-list-0010"> <li> <p>Very low quality evidence: three of the domains are not met. We are very uncertain about the results. </p> </li> </ul> <ul id="CD011681-list-0011"> <li> <p>No evidence: no RCTs were identified that addressed this outcome.</p> </li> </ul> </p> </section> </section> <section id="CD011681-sec-0052"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We investigated the effects of the following subgroup analyses.</p> <p> <ol id="CD011681-list-0012"> <li> <p>Trials in which patients were depressed (as determined by a rating scale or clinical interview) versus trials in which patients were not depressed. </p> </li> <li> <p>Trials evaluating the various SSRIs and SNRIs separately.</p> </li> </ol> </p> </section> <section id="CD011681-sec-0053"> <h4 class="title">Sensitivity analysis</h4> <p>We did not plan any sensitivity analysis.</p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011681-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011681-sec-0054"></div> <section id="CD011681-sec-0055"> <h3 class="title">Description of studies</h3> <section id="CD011681-sec-0056"> <h4 class="title">Results of the search</h4> <p>The new electronic search up to November 2014 retrieved a total of 4508 results after discarding duplicates. After retrieving full‐text articles, we included two new studies (120 participants) (<a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>; <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>), along with the six studies already included. We classified one study published only as a poster presentation (<a href="./references#CD011681-bbs2-0025" title="GabrielidouP , LekkouG , RobotisA , PapatriantafillouJ , ManiasP , KaragiannisV , et al. Venlafaxine versus amitriptyline for the prophylaxis of tension type headache. 4th European Headache Congress. 1998. ">Gabrielidou 1998</a>), one Chinese (<a href="./references#CD011681-bbs2-0027" title="ZhouHY , ZhouD . Influence of venlafaxine hydrochloride on the quality of life in patients with chronic tension headache. [Chinese]. Chinese Journal of Clinical Rehabilitation2006;10(10):26‐8. ">Zhou 2006</a>), and one Russian (<a href="./references#CD011681-bbs2-0026" title="TarasovaSV , AmelinAV , SkorometsAA . Fluvoxamine, amitriptyline and transcranial electrostimulation of the brain in the treatment of chronic daily headache. Zhurnal Nevropatoliogii I Psikhiatrii Imeni SS Korsakova2009;108:43‐6. ">Tarasova 2008</a>) publication as awaiting classification (<a href="./references#CD011681-sec-0117" title="">Characteristics of studies awaiting classification</a>). We did not find ongoing studies by searching clinical trial registries. </p> <p>See <a href="#CD011681-fig-0001">Figure 1</a> (<a href="./references#CD011681-bbs2-0045" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GøtzschePC , et al. The PRISMA Statement for Reporting Systematic Reviews and Meta‐Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Med2009;6(7):e1000100. ">Liberati 2009</a>). </p> <div class="figure" id="CD011681-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram." data-id="CD011681-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram.</p> </div> </div> </div> </section> <section id="CD011681-sec-0057"> <h4 class="title">Included studies</h4> <p>Overall, we included eight studies published between 1993 and 2007 in this updated review (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>; <a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>; <a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>; <a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>; <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>). </p> <p>Two trials were multicentric (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>; <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>). The median length of studies was 12 weeks (range: eight to 24). </p> <p>All but two (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>) were parallel trials. <a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a> was a three‐arm cross‐over trial comparing two active interventions (citalopram and amitriptyline) and placebo. In this study patients were treated for an 8‐week period with each treatment, with a washout period (two weeks) between treatments. Carry‐over and time period effects were not present. Therefore, this study was analysed as if it were a parallel‐group trial, combining data from all treatment periods. In <a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a> a response‐conditional cross‐over design was used: only patients considered non‐responders or patients with intolerable adverse events were crossed over to the alternative treatment, without a washout period in between. Since SSRIs and SNRIs are long‐acting agents, we considered 'carry‐over' and 'period' effects to potentially affect the results of this trial. Thus, we used only data from the first period of this cross‐over study. </p> <p>The washout period was only described in four studies (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>; <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>). </p> <p>See <a href="./references#CD011681-sec-0115" title="">Characteristics of included studies</a>. </p> <section id="CD011681-sec-0058"> <h5 class="title">Participants</h5> <p>The included studies enrolled a total of 412 participants, with women generally more represented than men (68% versus 32%). <a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a> only reported that males outnumbered females, but provided no data. <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a> did not report sex of non‐completers. The mean age of the participants ranged from 28 (<a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>) to 42 (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>) years old. </p> <p>All the studies included participants affected by chronic forms of tension‐type headache. Seven studies (N = 362) enrolled patients with chronic tension‐type headache diagnosed following the diagnostic criteria of IHS (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>; <a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>; <a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>; <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>). <a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a> (N = 50) did not specify the diagnostic criteria for the selection of participants. <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a> also included a subgroup of patients with episodic tension‐type headache and <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a> included all subtypes of tension‐type headache. </p> <p>Two studies (<a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>) included depressed participants but only <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a> compared depressed and non‐depressed subjects. In the remaining studies, depressed subjects were clearly excluded. Only one study excluded participants with acute medication overuse (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>). </p> <p>The median number of participants randomised in the included studies was 52 and ranged from 37 (<a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>) to 90 (<a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>). Losses to follow‐up were moderate, reaching 20% in one trial only (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>). </p> </section> <section id="CD011681-sec-0059"> <h5 class="title">Interventions and controls</h5> <p>Two studies compared two SSRIs (citalopram (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>); sertraline (<a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>)) and one SNRI (venlafaxine (<a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>)) with placebo. The remaining trials compared SSRIs (citalopram (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>); fluoxetine (<a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>); sertraline (<a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>); paroxetine (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>); and fluvoxamine (<a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>) with other antidepressant agents (amitriptyline) (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>; <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>); sulpiride (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>); mianserin (<a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>); and desipramine (<a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>). </p> <p>Escalation of the SSRI dose was permitted (i.e. paroxetine to a maximum of 30 mg/day; fluvoxamine to a maximum of 100 mg/day; fluoxetine to a maximum of 40 mg/day) in three studies (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>; <a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>). The remaining studies used fixed doses of experimental antidepressant. In the active‐comparator trials, the antidepressant dose in the control arm was increased progressively over the first two weeks of treatment. </p> <p>The only trial evaluating SNRI (<a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>) used an extended release formulation of venlafaxine in a daily dosage of 150 mg (two capsules containing a 75 mg dose). </p> <p>We did not identify any study comparing SSRIs or SNRIs with a drug treatment other than antidepressants or with a non‐pharmacological treatment (behavioural or physical therapy). We did not find any study comparing two different SSRIs or SNRIs head‐to‐head. </p> <p>See <a href="./references#CD011681-sec-0115" title="">Characteristics of included studies</a>. </p> </section> <section id="CD011681-sec-0060"> <h5 class="title">Country and language of publication</h5> <p>Two studies were carried out in Turkey (<a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>; <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>), two in Denmark (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>), and one each in Greece (<a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>), the UK (<a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>), Italy (<a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>), and India (<a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>). All were published in English. </p> </section> </section> <section id="CD011681-sec-0061"> <h4 class="title">Excluded studies</h4> <p>In the original review, we excluded nine studies because they were not randomised, two because they were case reports, and one because the license of the SSRI studied (femoxetine) had been discontinued by drug companies (company communication, Knoll, February 1988, and Martec, February 1990). In the original review, two studies (<a href="./references#CD011681-bbs2-0021" title="SaperJR , SilbersteinSD , LakeAE3rd , WintersME . Double‐blind trial of fluoxetine: chronic daily headache and migraine. Headache1994;34(9):497‐502. ">Saper 1994</a> and <a href="./references#CD011681-bbs2-0012" title="BussoneG , SandriniG , PatrunoG , RuizL , TassorelliC , NappiG . Effectiveness of fluoxetine on pain and depression in chronic headache disorders. In: NappiG , BonoG , SandriniG , MartignoniE , MicieliG editor(s). Headache and depression: serotonin pathways as a common clue. New York: Raven Press, 1991:265‐72. ">Bussone 1991</a>) were excluded because it was impossible to separate data on patients with migraine from data on patients with chronic daily headache or chronic tension‐type headache. We contacted the authors, who confirmed that study data and analyses are no longer available. In this update, we excluded one study (<a href="./references#CD011681-bbs2-0019" title="RampelloL , AlvanoA , ChiechioS , MalaguarneraM , RaffaeleR , VecchioI , et al. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension‐type headache. Neuropsychobiology2004;50:322‐8. ">Rampello 2004</a>) because it recruited patients with comorbidity of depression, migraine, or tension‐type headache. </p> <p>We excluded a Russian publication previously judged as a study awaiting classification because of the lack of a control group. (<a href="./references#CD011681-bbs2-0024" title="VoznesenskaiaTG . Prozac treatment of chronic tension headache [Lechenie prozakom khronicheskikh golovnykh bolei napriazheniia]. Zhurnal Nevrologii i Psikhiatr ii Imeni S.S. Korsakova1999;99(1):34‐6. ">Voznesenskaia 1999</a>). </p> <p>See <a href="./references#CD011681-sec-0116" title="">Characteristics of excluded studies</a> and <a href="#CD011681-fig-0001">Figure 1</a>. </p> </section> </section> <section id="CD011681-sec-0062"> <h3 class="title">Risk of bias in included studies</h3> <p>The overall risk of bias is presented graphically in <a href="#CD011681-fig-0002">Figure 2</a> and summarised in <a href="#CD011681-fig-0003">Figure 3</a>. The majority of included trials had methodological or reporting shortcomings. We cannot exclude the fact that poor reporting could have affected our assessment. </p> <div class="figure" id="CD011681-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011681-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011681-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011681-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011681-sec-0063"> <h4 class="title">Allocation</h4> <p>Only one trial reported an adequate random sequence generation and concealment and was then judged at low risk of selection bias (<a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>). For <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>, we were able to contact the authors and obtain additional information: the generation of sequence was done using computer software (not specified), and there was no attempt to conceal patient assignment. The remaining studies did not provide any information useful to evaluate how the random sequence was generated and concealed, and so we judged these at unclear risk of selection bias. </p> </section> <section id="CD011681-sec-0064"> <h4 class="title">Blinding</h4> <p>Three studies (33%) were double‐blind and reported information on how participants, physicians, or both, were blinded to the study treatments (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>; <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>). We judged at high risk of bias two open‐label studies (<a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>; <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>), and one in which drugs were identical in appearance, but the two groups received different numbers of tablets (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>). For the two remaining trials we did not have sufficient details to judge how the blinding was planned and maintained. </p> </section> <section id="CD011681-sec-0065"> <h4 class="title">Incomplete outcome data</h4> <p>We judged four studies (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>; <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>; <a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>) at low risk of attrition bias, while three trials (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>; <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>) were at high risk due to a moderate dropout rate unbalanced across arms and with reasons for drop out not fully reported. <a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a> did not report if there were withdrawals after randomisation. </p> </section> <section id="CD011681-sec-0066"> <h4 class="title">Selective reporting</h4> <p>We did not find any information that allowed us to assess the possible selective reporting of studies and outcomes. None of the trials included in this version of the review are registered nor have a publicly available protocol for consultation. All the studies used multiple outcomes without a predefined primary outcome and multiple time points for the assessment. This suggests possible selective outcome reporting. </p> </section> <section id="CD011681-sec-0067"> <h4 class="title">Other potential sources of bias</h4> <p>Four studies did not provide any information about financial sponsorship (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>; <a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>). We judged at high risk of bias for commercial sponsorship two studies supported by the manufacturer of the antidepressants being tested (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>), and one in which the 'drug company' was responsible for randomisation and blinding (<a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>). <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a> was an independent trial without financial support. </p> <p>Only one of the included studies reported an adequate sample size calculation (<a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>). Most of the studies were clearly underpowered and, therefore, more prone to be inconclusive (e.g. not enabled to find a statistically significant difference which is true) (<a href="./references#CD011681-bbs2-0029" title="AltmanDG , DoreCJ . Randomisation and baseline comparisons in clinical trials. Lancet1990;335(8682):149‐53. ">Altman 1990</a>; <a href="./references#CD011681-bbs2-0038" title="HotopfM , LewisG , NormandC . Putting trials on trial ‐ the costs and consequences of small trials in depression: a systematic review of methodology. Journal of Epidemiology and Community Health1997;51(4):354‐8. ">Hotopf 1997</a>; <a href="./references#CD011681-bbs2-0039" title="HotopfM , ChurchillR , LewisG . Pragmatic randomised controlled trials in psychiatry. British Journal of Psychiatry1999;175:217‐23. ">Hotopf 1999</a>). The median sample size was 45 and ranged from 35 to 90. The mean dropout rate was 16% of all randomised patients, leading to much smaller sample sizes across studies. </p> <p>With respect to the previous version of this review which considered both migraine and tension‐type headache, the median sample size per arm nearly doubled (25 to 45). However, concerns remain about the fact that many studies are likely to be underpowered to detect any difference (<a href="./references#CD011681-bbs2-0066" title="MojaPL , CusiC , SterziRR , CanepariC . Selective serotonin re‐uptake inhibitors (SSRIs) for preventing migraine and tension‐type headaches. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD002919.pub2] ">Moja 2005</a>). </p> <p>The lack of statistical power is also reflected in the use of a large number of rating scales to measure outcomes. Furthermore, the majority of trials analysed the multiple outcomes at many different time intervals (four weeks, eight weeks, etc.), increasing exponentially the number of comparisons. Performing multiple comparisons easily leads to detecting statistically significant differences that are spurious (<a href="./references#CD011681-bbs2-0060" title="ThornleyB , AdamsC . Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ1998;317(7167):1181‐4. ">Thornley 1998</a>). Only two studies (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>) stated that some form of correction for multiple testing was used (Bonferroni's correction). </p> <p>The majority of the trials actually conducted per protocol analyses for the participants who completed the study period only. <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a> described that statistical analysis of patient's withdrawal was performed using the last‐observation‐carried‐forward (LOCF) method. In many trials, the reporting of missing data was unclear. </p> </section> </section> <section id="CD011681-sec-0068"> <h3 class="title" id="CD011681-sec-0068">Effects of interventions</h3> <p>See: <a href="./full#CD011681-tbl-0001"><b>Summary of findings for the main comparison</b> SSRIs or SNRIs versus placebo for tension‐type headache</a>; <a href="./full#CD011681-tbl-0002"><b>Summary of findings 2</b> SSRIs or SNRIs versus other antidepressants for tension‐type headache</a> </p> <p>When possible, for each efficacy outcome, we focused on outcomes at two different follow‐up time points in the same analysis graph (eight and 12 weeks). </p> <section id="CD011681-sec-0069"> <h4 class="title">SSRIs or SNRIs versus placebo</h4> <p>Two new studies (<a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>; <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>) and one study already included in the previous version of this review (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>) compared SSRIs or SNRIs to placebo. The drugs under investigation were citalopram, sertraline, and venlafaxine. None of these trials reported data on quality of life, workdays lost, or cost‐effectiveness outcomes. </p> <p>We estimated standard deviations for all continuous outcomes reported by <a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>. <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a> reported efficacy data at different follow‐up periods (three, eight, 12 weeks). Data at eight and 12 weeks follow‐up were similar. We pooled results at eight weeks as <a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a> also reported data at this follow‐up. </p> <p><a href="./full#CD011681-tbl-0001">summary of findings Table for the main comparison</a> summarises data on this comparison. </p> <section id="CD011681-sec-0070"> <h5 class="title">Primary outcome</h5> <section id="CD011681-sec-0071"> <h6 class="title">Headache frequency</h6> <p>One new study (<a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>), and one study already included in the previous version of this review (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>), with a total of 127 participants, reported data on headache frequency, the primary outcome of this review. At eight weeks follow‐up, we found no differences in terms of number of days with headache (MD ‐0.96, 95% CI ‐3.95 to 2.03; I<sup>2</sup> = 0%; <a href="./references#CD011681-fig-0007" title="">Analysis 1.1</a>; <a href="#CD011681-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD011681-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 SSRIs or SNRIs versus placebo, outcome: 1.1 Headache frequency (number of headache days) (follow‐up: 8 weeks)." data-id="CD011681-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 SSRIs or SNRIs versus placebo, outcome: 1.1 Headache frequency (number of headache days) (follow‐up: 8 weeks). </p> </div> </div> </div> </section> </section> <section id="CD011681-sec-0072"> <h5 class="title">Secondary outcomes</h5> <section id="CD011681-sec-0073"> <h6 class="title">Headache intensity</h6> <p>Only <a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a> reported data on headache intensity (MD ‐0.30, 95% CI ‐1.13 to 0.53). </p> </section> <section id="CD011681-sec-0074"> <h6 class="title">Headache duration</h6> <p>Only <a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a> reported data on headache duration (hours per day) (MD ‐0.07, 95% CI ‐2.69 to 2.55). </p> </section> <section id="CD011681-sec-0075"> <h6 class="title">Symptomatic/analgesic medication use for acute headache attacks</h6> <p>One new study (<a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>) and one study already included in the previous version of this review (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>), with a total of 118 participants, reported data on symptomatic/analgesic medication use for acute headache attacks. At eight weeks follow‐up, SSRIs seem to reduce the mean analgesic intake compared to placebo of about two doses per month (MD ‐1.87, 95% CI ‐2.09 to ‐1.65; I<sup>2</sup> = 0%; <a href="./references#CD011681-fig-0008" title="">Analysis 1.2</a>; <a href="#CD011681-fig-0005">Figure 5</a>). This finding is largely driven by the results of a study at high risk of sponsorship bias (<a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>). </p> <div class="figure" id="CD011681-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 SSRIs or SNRIs versus placebo, outcome: 1.2 Symptomatic/analgesic medication use (doses/month) (follow‐up: 8 weeks)." data-id="CD011681-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 SSRIs or SNRIs versus placebo, outcome: 1.2 Symptomatic/analgesic medication use (doses/month) (follow‐up: 8 weeks). </p> </div> </div> </div> </section> <section id="CD011681-sec-0076"> <h6 class="title">Headache index</h6> <p>One new study (<a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>), and one study already included in the previous version of this review (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>), with a total of 128 participants, reported data on headache indexes (calculated by multiplying the hours with headache by its severity). At eight weeks follow‐up, we found no significant differences in headache index (SMD ‐0.24, 95% CI ‐0.59 to 0.11; I<sup>2</sup> = 0%; <a href="./references#CD011681-fig-0009" title="">Analysis 1.3</a>). <a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a> also reported data on headache index (calculated as the product of headache frequency per week by severity by duration). However, we did not pool this data in the meta‐analysis, as the reporting on this outcome was unclear and apparently referred only to the within‐group change. </p> </section> <section id="CD011681-sec-0077"> <h6 class="title">Withdrawals from treatment</h6> <p>All three studies provided data on withdrawals from treatment. <a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a> reported two dropouts in the citalopram group and three in the placebo, while <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a> reported nine in the venlafaxine group and 11 in the placebo arm. The reporting of withdrawals in <a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a> was unclear: out of the 10 patients who dropped out, we did not consider those excluded in the run‐in period (N = 2), as this is likely to occur before randomisation. The remaining eight dropped out during the follow‐up period (N = 2, and not clear from which arm) and the study treatment (N = 6, five in the placebo arm). The pooled estimate of withdrawals for any reason did not differ between SSRIs or SNRIs and placebo (Peto odds ratio (OR) 0.54, 95% CI 0.25 to 1.19; I<sup>2</sup> = 0%; <a href="./references#CD011681-fig-0010" title="">Analysis 1.4</a>). </p> <p>Data on patients withdrawing from treatment due to adverse events were few and sparse. <a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a> reported that none of the patients had any side effects necessitating withdrawals. We found no evidence of a difference (Peto OR 3.72, 95% CI 0.79 to 17.53; I<sup>2</sup> = 69%; <a href="./references#CD011681-fig-0011" title="">Analysis 1.5</a>). </p> </section> <section id="CD011681-sec-0078"> <h6 class="title">Minor adverse events</h6> <p><a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a> reported only aggregated data on adverse events. Two studies (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>) contributed to the meta‐analysis (Peto OR 1.57, 95% CI 0.52 to 4.76; I<sup>2</sup> = 46%; <a href="./references#CD011681-fig-0012" title="">Analysis 1.6</a>). </p> </section> </section> </section> <section id="CD011681-sec-0079"> <h4 class="title">SSRIs and SNRIs versus another active drug (other antidepressants)</h4> <p>We did not find any new study comparing SSRIs or SNRIs to other antidepressants. Three studies already included in the previous version of this review (<a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>) provided incomplete data, such that it was not possible to include them in the meta‐analyses of continuous outcome data. </p> <p><a href="./full#CD011681-tbl-0002">summary of findings Table 2</a> summarises data on this comparison. </p> <section id="CD011681-sec-0080"> <h5 class="title">Primary outcome</h5> <section id="CD011681-sec-0081"> <h6 class="title">Headache frequency</h6> <p>Two studies already included in the previous version of this review (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>) with a total of 152 participants reported data on headache frequency (number of days with headache per month) that could be used in the meta‐analysis. At eight weeks, the pooled estimate MD using a random‐effects model was 0.76 (95% CI ‐2.05 to 3.57; I<sup>2</sup> = 44%; <a href="./references#CD011681-fig-0013" title="">Analysis 2.1</a>; <a href="#CD011681-fig-0006">Figure 6</a>). Heterogeneity was moderate. At 12 weeks, only <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a> reported data (MD 0.80, 95% CI ‐1.29 to 2.89; <a href="./references#CD011681-fig-0013" title="">Analysis 2.1</a>). </p> <div class="figure" id="CD011681-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 SSRIs or SNRIs versus another antidepressants, outcome: 2.1 Headache frequency (number of headache days)." data-id="CD011681-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 SSRIs or SNRIs versus another antidepressants, outcome: 2.1 Headache frequency (number of headache days). </p> </div> </div> </div> <p><a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a> described only within‐group results for the overall study population at eight weeks (both fluvoxamine and mianserin significantly (P &lt; 0.01) reduced the number of days with headache), but stated that fluvoxamine was significantly better than mianserin for this outcome among non‐depressed patients (P &lt; 0.05); no quantitative data were reported. <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a> described only within‐group analyses of data on headache frequency (number of days with headache) and reported no quantitative data. Among patients with chronic tension‐type headache (N = 13), fluoxetine was significantly effective only at eight weeks, while amitriptyline reduced headache frequency significantly at both eight and 12 weeks; among patients with episodic tension‐type headache (N = 19), the situation was reversed: fluoxetine was significantly effective at eight and 12 weeks, while amitriptyline reduced headache frequency only at eight weeks. </p> </section> </section> <section id="CD011681-sec-0082"> <h5 class="title">Secondary outcomes</h5> <section id="CD011681-sec-0083"> <h6 class="title">Headache intensity</h6> <p>As for the primary outcome, only two studies already included in the previous version of this review (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>), with a total of 152 participants, reported data on headache intensity (using a 10‐point scale to assess severity) that could be used in the meta‐analysis. At eight weeks, we found no evidence for a difference (MD: 0.32, 95% CI ‐0.55 to 1.19; I<sup>2</sup> = 72%; <a href="./references#CD011681-fig-0014" title="">Analysis 2.2</a>). Heterogeneity between the studies was substantial. At 12 weeks (<a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>) the tricyclic antidepressant amitriptyline showed a better efficacy than the SSRI sertraline (MD 1.70, 95% CI 1.06 to 2.34; <a href="./references#CD011681-fig-0014" title="">Analysis 2.2</a>). </p> <p>Four additional studies assessed headache intensity but provided data which cannot be pooled in the meta‐analysis: <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>, <a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a> and <a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a> used ordinal scales of 10, 5, and 3 points, respectively, to assess headache intensity, while <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a> did not clearly define the severity measure used. <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a> found no differences between fluoxetine and desipramine in change of pain score from baseline to three months; no quantitative data were reported. <a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a> reported that at eight weeks headache severity scores were decreased from baseline levels with both paroxetine (mean change: ‐0.4) and sulpiride (mean change: ‐0.7); there was no difference between the two treatments (P = 0.24). <a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a> described only within‐group headache severity results for the overall study population at eight weeks (both fluvoxamine and mianserin reduced headache severity: P &lt; 0.01), but stated that fluvoxamine was "significantly better than mianserin" for this outcome among non‐depressed patients (P &lt; 0.05); no quantitative data were reported. <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a> described only within‐group analyses of results for headache severity and reported no quantitative data. Among patients with chronic tension‐type headache (N = 13), "neither drug was effective against pain intensity." Among patients with episodic tension‐type headache (N = 19), fluoxetine significantly reduced pain severity at eight weeks, but not at 12 weeks; amitriptyline had no significant effect. </p> </section> <section id="CD011681-sec-0084"> <h6 class="title">Headache duration</h6> <p>Two studies already included in the previous version of this review (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>), with a total of 152 participants, reported data on headache duration. <a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a> reported duration results as headache hours per four weeks; we recalculated the data as headache hours per day. At eight weeks, the MD was 1.26 (95% CI 0.06 to 2.45; I<sup>2</sup> = 0%; <a href="./references#CD011681-fig-0015" title="">Analysis 2.3</a>), slightly favouring amitriptyline. This trend was confirmed at 12 weeks follow‐up (<a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>) (MD 1.30, 95% CI ‐0.39 to 2.99; <a href="./references#CD011681-fig-0015" title="">Analysis 2.3</a>). </p> </section> <section id="CD011681-sec-0085"> <h6 class="title">Symptomatic/analgesic medication use for acute headache attacks</h6> <p>This outcome was considered in four studies already included in the previous version of this review, but only two (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>) reported quantitative data. At eight weeks, the pooled estimate MD (doses/four weeks) was 4.98 (95% CI 1.12 to 8.84; I<sup>2</sup>= 0%; <a href="./references#CD011681-fig-0016" title="">Analysis 2.4</a>), favouring tricyclic antidepressants. At 12 weeks, only <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a> reported data, which again favoured amitriptyline (MD 5.40, 95% CI 1.10 to 9.70; <a href="./references#CD011681-fig-0016" title="">Analysis 2.4</a>). </p> <p>Of the two studies that cannot be pooled, <a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a> reported that at eight weeks the number of analgesic tablets taken per day had significantly decreased compared to baseline with both paroxetine (mean change: ‐0.8 tablets; P &lt; 0.05) and sulpiride (mean change: ‐1.3 tablets; P &lt; 0.005); there was no significant difference between the two treatments (P = 0.39). <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a> reported no significant differences between fluoxetine and desipramine in reduction in analgesic intake from baseline to three months; no quantitative data were reported. </p> </section> <section id="CD011681-sec-0086"> <h6 class="title">Headache index</h6> <p>Two studies already included in the previous version of this review reported results for this outcome: <a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a> utilised a migraine headache index that combined intensity and duration of headache, while <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a> calculated the headache index as headache frequency times average intensity times duration divided by 28 days. It was possible to combine results from the two studies only at eight weeks: the pooled estimate included 152 patients, of whom 75 received a SSRI (citalopram or sertraline) and 77 a tricyclic antidepressant (amitriptyline). The SMD when using a random‐effects model was 0.42 (95% CI 0.00 to 0.85; I<sup>2</sup> = 42%; <a href="./references#CD011681-fig-0017" title="">Analysis 2.5</a>), favouring the tricyclic antidepressant. <a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a> reported that the difference between amitriptyline and placebo was statistically significant (P = 0.002) favouring amitriptyline, whereas the difference between citalopram and placebo was not significant (P = 0.68). </p> <p>At 12 weeks, only <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a> reported data: the resulting SMD was 0.51 (95% CI 0.08 to 0.95; <a href="./references#CD011681-fig-0017" title="">Analysis 2.5</a>), again favouring the tricyclic antidepressant. <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a> also reported the number of patients with more than a 50% reduction in headache index after 12 weeks: significantly more patients improved up to the threshold in the amitriptyline group than in the sertraline group (OR 0.30; 95% CI 0.12 to 0.75). </p> </section> <section id="CD011681-sec-0087"> <h6 class="title">Quality of life</h6> <p>Only <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a> reported results for this outcome. Investigators used the Medical Outcomes Study, Short Form‐36 (SF‐36) to assess quality of life. They reported that SF‐36 scores were significantly improved at 12 weeks on all but two subscales ('role functioning‐emotional' and 'social functioning') among patients who completed the trial (N = 25, both treatment groups combined), and that there was no significant difference between the two treatment groups for this outcome. No between‐group P values were reported, and the quantitative data reported were not broken down by treatment group. </p> </section> <section id="CD011681-sec-0088"> <h6 class="title">Withdrawals from treatment</h6> <p>Four trials already included in the previous version of this review (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>; <a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>) contributed data to these analyses. <a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>, a cross‐over trial appropriately designed and executed, reported the dropouts for both periods, therefore we counted the enrolled patients in both arms. Overall, these analyses included 217 participants: 127 received a SSRI and 130 another antidepressant. Among participants receiving a SSRI, 14.2% (18) withdrew from treatment, compared with 10.0% (13) of those receiving other antidepressants. There was no significant difference between the two treatments (Peto OR 1.55, 95% CI 0.71 to 3.38; I<sup>2</sup> = 0%; <a href="./references#CD011681-fig-0018" title="">Analysis 2.6</a>). Among the participants receiving a SSRI, 8.7% (11/127) withdrew from treatment because of an adverse event, compared with 8.5% (11/130) of those treated with the other antidepressants. There was no significant difference between the two treatments (Peto OR 1.04, 95% CI 0.41 to 2.60; I<sup>2</sup> = 25%; <a href="./references#CD011681-fig-0019" title="">Analysis 2.7</a>). Reasons for withdrawals are specified in the <a href="./references#CD011681-sec-0115" title="">Characteristics of included studies</a> tables. </p> </section> <section id="CD011681-sec-0089"> <h6 class="title">Minor adverse events</h6> <p>Five of the six included trials reported some data on minor adverse effects (<a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a>; <a href="./references#CD011681-bbs2-0002" title="BozC , AltunayogluV , VeliogluS , OzmenogluM . Sertraline versus amitriptyline in the prophylactic therapy of non‐depressed chronic tension‐type headache patients. Journal of Headache and Pain2003;4(2):72‐8. ">Boz 2003</a>; <a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>; <a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>). Only <a href="./references#CD011681-bbs2-0001" title="BendtsenL , JensenR , OlesenJ . A non‐selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension‐type headache. Journal of Neurology, Neurosurgery and Psychiatry1996;61(3):285‐90. ">Bendtsen 1996</a> reported the overall number of patients with adverse events in a form we could analyse (data were referred to case‐person and not to the overall numbers of adverse effects). In this trial investigators found that amitriptyline induced significantly more minor adverse effects than citalopram (OR 0.13, 95% CI 0.05 to 0.36). The most frequent minor adverse effects in the amitriptyline group were drowsiness and dry mouth. The number needed to treat to harm was eight (95% CI 3 to 20). </p> </section> <section id="CD011681-sec-0090"> <h6 class="title">Mood improvement</h6> <p>Two studies (<a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>) evaluated the effect on depression, neither of which reported useable quantitative data. <a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a> evaluated patients using the Zung Self‐Rating Depression Scale and the Hamilton Depression Rating Scale. At baseline, 12 of 20 patients in the fluvoxamine group were diagnosed with slight or mild mood depression, and 13 of 20 in the mianserin group received the same diagnosis. After eight weeks of treatment, investigators reported that scores on both scales were significantly improved in both treatment groups (P &lt; 0.01), with no significant difference between the two groups on either scale (no P values reported). The data were given only in the form of histograms, and depressed patients were not analysed as a subgroup of interest. </p> <p><a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a> used the Hospital Anxiety and Depression Scale (HADS) and the Montgomery and Asberg Depression Rating Scale (MADRS) to evaluate patients. Using MADRS, eight of 37 patients (22%) entering the trial (both treatment groups combined) were depressed; using HADS with a cut‐off score of 20, 12 of 37 (32%) had depression. Investigators reported that both MADRS and HADS scores were significantly improved at 12 weeks among patients who completed the trial (N = 25, both treatment groups combined), and that there was no significant difference between the two groups for this outcome. No between‐group P values were reported, and the quantitative data reported were not broken down by treatment group. </p> </section> </section> </section> <section id="CD011681-sec-0091"> <h4 class="title">Planned subgroup analyses</h4> <p>Two trials (<a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>) enrolled both participants with and without depression, but did not provide subgroup data. </p> <p>Due to the low number of studies included, we could not analyse the different SSRIs and SNRIs separately. </p> </section> <section id="CD011681-sec-0092"> <h4 class="title">Prevention of transformation to a chronic headache syndrome</h4> <p>We did not find studies focusing on whether SSRIs or SNRIs can prevent the transformation of episodic into chronic tension‐type headache. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011681-sec-0093" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011681-sec-0093"></div> <section id="CD011681-sec-0094"> <h3 class="title" id="CD011681-sec-0094">Summary of main results</h3> <p>Evidence supporting the use of SSRIs or SNRIs to decrease headache frequency ‐ the most relevant clinical outcome in adults with frequent episodic or chronic tension‐type headache ‐ is scarce. We included two new studies in this update, one on the SSRI sertraline (<a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>) and one on the SNRI venlafaxine (<a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>), which did not provide any new substantial evidence in the field. Overall, we identified seven studies comparing SSRIs with placebo and with other antidepressants (amitriptyline, desipramine, mianserin, sulpiride) and one study comparing the SNRI venlafaxine with placebo. We did not find studies comparing SSRIs or SNRIs with non‐antidepressant drug treatments for preventing headache (e.g. tizanidine, botulinum toxin) or with physical or behavioural treatments for headache. SSRIs and SNRIs are not better than placebo or tricyclic antidepressants in reducing the number of days with headache at 8 weeks of follow‐up. </p> <p>Among secondary outcomes, we found that SSRIs or SNRIs did not reduce headache intensity and duration and did not improve headache index when compared to placebo after 8 or 12 weeks of treatment. One trial at high risk of bias for commercial sponsorship (<a href="./references#CD011681-bbs2-0006" title="SinghN , MisraS . Sertraline in chronic tension‐type headache. Journal of the Association of Physicians of India2002;50:873‐8. ">Singh 2002</a>) suggested that sertraline can reduce the use of symptomatic/analgesic medications by 1.87 doses/week compared to placebo. Amitriptyline, a tricyclic antidepressant, appeared to be more effective in reducing headache intensity and duration especially at longer follow‐up (12 and 16 weeks). Our results also showed a significantly higher intake of symptomatic/analgesic medication in patients treated with SSRIs than in patients treated with tricyclic antidepressants, equivalent to five more doses per month (95% CI 1 to 9; two studies, N = 152). Results may have been confounded by the inclusion of participants with and without acute medication overuse. </p> <p>The data on the safety profile of SSRIs and SNRIs derived from the included studies were also scarce. The included studies analysed a small number of participants, and thus they lack the power to detect adverse events. Moreover, the reporting of adverse events was generally unclear. No differences in terms of dropouts due to adverse events or minor adverse events were detected compared with placebo or other antidepressants. SSRIs and SNRIs appeared to be better tolerated than the tricyclic antidepressant, amitriptyline, but no conclusions can be drawn on the basis of the included trials. </p> <p>Tension‐type headache affects many aspects of an individual's life, including both social and occupational roles. We did not find any mention of days off work or any data on cost‐effectiveness. Days off work is a specific, strong measure to assess headache improvement from a more socio‐economic perspective. Only one study analysed quality of life, using the SF‐36 Medical Outcomes Study (<a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>), and did not find any significant difference between fluoxetine and desipramine. Several quality of life scales have been validated and are now available. They assess the impact that headache has on activities of daily living and include many items related to general well‐being such as pain and mood states. Many headache indexes used in headache trials replicate some subscale or items already included in quality of life scales. However, the validity of some of the rating tools adopted in the trials is unknown, the clinical relevance questionable, and the use seems rather opportunistic (<a href="./references#CD011681-bbs2-0049" title="MojaL , VirgiliG , LiberatiA , GensiniGF , GusinuR , ContiAA . Scales to climb borderline personalities: when science goes nowhere. Internal and Emergency Medicine2007;2(4):315‐7. ">Moja 2007</a>). Finally, quality of life is a global measure capable of making useful comparisons between adverse events of drugs (<a href="./references#CD011681-bbs2-0038" title="HotopfM , LewisG , NormandC . Putting trials on trial ‐ the costs and consequences of small trials in depression: a systematic review of methodology. Journal of Epidemiology and Community Health1997;51(4):354‐8. ">Hotopf 1997</a>). </p> <p>We cannot draw any conclusions about possible differences in efficacy or safety profile between SSRIs and SNRIs. Due to the small amount of evidence in the field and its low quality, it was not possible to explore subgroup differences in efficacy related to different selectivity profiles. </p> </section> <section id="CD011681-sec-0095"> <h3 class="title" id="CD011681-sec-0095">Overall completeness and applicability of evidence</h3> <p>Data that inform this review are few and derived from poorly designed, conducted, and reported trials. Five studies reported data on the most relevant clinical outcome, headache frequency, however only four could be pooled in meta‐analyses, for a total of fewer than 200 participants. All the included studies assessed participants who had been diagnosed with chronic tension‐type headache. Fewer participants with episodic tension‐type headache were included in one study, thus we cannot draw any conclusion on the efficacy and safety of SSRIs and SNRIs in this population. Reporting was often incomplete, making some studies uninformative. The applicability of this scarce evidence is also an issue, mainly because the analysed studies used short follow‐up and outcomes with small clinical value. Having said that, the findings of this review suggest that the use of SSRIs and SNRIs do not provide benefits that may matter to patients. </p> </section> <section id="CD011681-sec-0096"> <h3 class="title" id="CD011681-sec-0096">Quality of the evidence</h3> <p>All the included trials can be considered at unclear or high risk of bias (see <a href="#CD011681-sec-0062">Risk of bias in included studies</a>). Six out of eight studies did not report information on the random sequence generation and allocation concealment. Four trials were in fact open‐label in a field in which blinding is highly desirable (<a href="./references#CD011681-bbs2-0064" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ2008;336(7644):601‐5. ">Wood 2008</a>). Two studies did not provide information on how blinding was maintained. Another major concern is that almost all of the included trials are likely to be underpowered; only one reported how the sample size was calculated and a reference to the use of an intention‐to‐treat analysis (<a href="./references#CD011681-bbs2-0008" title="ZissisNP , HarmoussiS , VlaikidisN , MitsikostasD , ThomaidisT , GeorgiadisG , et al. A randomized, double‐blind, placebo‐controlled study of venlafaxine XR in out‐patients with tension‐type headache. Cephalalgia2007;27:315–24. ">Zissis 2007</a>). The small sample size is a consistent marker of overestimation of treatment effects. There was a strong inclination to perform multiple testing. Finally, there were frequent ambiguities in presentation of the results of the analyses, emphasising within‐group comparisons. Some readers may find these methodological problems surprising; we did not. Previous methodological work showed that these are common problems in studies of SSRIs and related antidepressants (<a href="./references#CD011681-bbs2-0038" title="HotopfM , LewisG , NormandC . Putting trials on trial ‐ the costs and consequences of small trials in depression: a systematic review of methodology. Journal of Epidemiology and Community Health1997;51(4):354‐8. ">Hotopf 1997</a>; <a href="./references#CD011681-bbs2-0039" title="HotopfM , ChurchillR , LewisG . Pragmatic randomised controlled trials in psychiatry. British Journal of Psychiatry1999;175:217‐23. ">Hotopf 1999</a>; <a href="./references#CD011681-bbs2-0060" title="ThornleyB , AdamsC . Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ1998;317(7167):1181‐4. ">Thornley 1998</a>) and, more generally, can be found across many medical specialties (<a href="./references#CD011681-bbs2-0029" title="AltmanDG , DoreCJ . Randomisation and baseline comparisons in clinical trials. Lancet1990;335(8682):149‐53. ">Altman 1990</a>). Methodological quality does not seem to have improved in the more recent trials. </p> <p>Even if we did not formally explore outcome reporting bias, the use of multiple, often overlapping, outcomes without a predefined primary outcome may increase the risk of data dredging and distorted reporting in the attempt to demonstrate post‐hoc differences between interventions (<a href="./references#CD011681-bbs2-0051" title="PocockSJ . Clinical trials with multiple outcomes: a statistical perspective on their design, analysis, and interpretation. Controlled Clinical Trials1997;18(6):530‐45. ">Pocock 1997</a>). This problem is magnified by the limited size of most included trials and the use of composite endpoints. Headache frequency is largely accepted as the most relevant clinical outcome. </p> <p>We rated the overall quality of evidence for clinically relevant efficacy and safety outcomes as having a ‘low’ or 'very low' level of evidence (<a href="./full#CD011681-tbl-0001">summary of findings Table for the main comparison</a> and <a href="./full#CD011681-tbl-0002">summary of findings Table 2</a>). We downgraded the overall quality of evidence in each outcome because of limitations in the study designs and imprecision. Indirectness and inconsistency also affected some outcomes such as headache frequency, index, and withdrawals due to adverse events. </p> </section> <section id="CD011681-sec-0097"> <h3 class="title" id="CD011681-sec-0097">Agreements and disagreements with other studies or reviews</h3> <p>Other systematic reviews (<a href="./references#CD011681-bbs2-0061" title="TomkinsGE , JacksonJL , O'MalleyPG , BaldenE , SantoroJE . Treatment of chronic headache with antidepressants: a meta‐analysis. American Journal of Medicine2001;111(1):54‐63. ">Tomkins 2001</a> and its update in <a href="./references#CD011681-bbs2-0043" title="JacksonJL , ShimeallW , SessumsL , DeZeeKJ , BecherD , DiemerM , et al. Tricyclic antidepressants and headaches: systematic review and meta‐analysis. BMJ2010;341:c5222. ">Jackson 2010</a>) examined antidepressant medication for tension‐type prophylaxis. Similar to our findings, the authors concluded that tricyclic antidepressants and SSRIs have a similar efficacy, in terms of number of days of tension‐type headache attacks, but tricyclics reduced the number of doses of analgesics taken for acute headache pain in patients with tension‐type headache. </p> <p>Recent clinical guidelines from the National Institute of Health and Care Excellence (NICE) reported that there was not enough evidence to recommend pharmacological prophylactic treatment for tension‐type headache (<a href="./references#CD011681-bbs2-0050" title="National Institute of Health and Care Excellence. Headaches: diagnosis and management of headaches in young people and adults. Clinical guidelines, CG150September 2012:187‐214. ">NICE 2012</a>). Even amitriptyline is not recommended, as the evidence of its effectiveness, supported by poor quality clinical trials, are traded‐off against relevant side effects. These conclusions can be considered in line with the evidence summarised in this review: tricyclics might be more effective than SSRIs, but their therapeutic role is limited by their scarce tolerability. The guidelines from the European Federation of Neurological Societies advise prevention of tension‐type headache using non‐drug management, although the scientific basis is limited. Concerns about the efficacy and tolerability of prophylactic drugs are raised, however, amitriptyline is still mentioned as the first choice drug, while mirtazapine and venlafaxine are considered second choice options (<a href="./references#CD011681-bbs2-0033" title="BendtsenL , EversS , LindeM , MitsikostasDD , SandriniG , SchoenenJ . EFNS guideline on the treatment of tension‐type headache ‐ Report of an EFNS task force. European Journal of Neurology2010;17:1318–25. ">Bendtsen 2010</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011681-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Flow diagram." data-id="CD011681-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011681-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011681-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 SSRIs or SNRIs versus placebo, outcome: 1.1 Headache frequency (number of headache days) (follow‐up: 8 weeks)." data-id="CD011681-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 SSRIs or SNRIs versus placebo, outcome: 1.1 Headache frequency (number of headache days) (follow‐up: 8 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 SSRIs or SNRIs versus placebo, outcome: 1.2 Symptomatic/analgesic medication use (doses/month) (follow‐up: 8 weeks)." data-id="CD011681-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 SSRIs or SNRIs versus placebo, outcome: 1.2 Symptomatic/analgesic medication use (doses/month) (follow‐up: 8 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 SSRIs or SNRIs versus another antidepressants, outcome: 2.1 Headache frequency (number of headache days)." data-id="CD011681-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 SSRIs or SNRIs versus another antidepressants, outcome: 2.1 Headache frequency (number of headache days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SSRIs or SNRIs versus placebo, Outcome 1 Headache frequency (number of headache days) (follow‐up: 8 weeks)." data-id="CD011681-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 SSRIs or SNRIs versus placebo, Outcome 1 Headache frequency (number of headache days) (follow‐up: 8 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SSRIs or SNRIs versus placebo, Outcome 2 Symptomatic/analgesic medication use (doses/month) (follow‐up: 8 weeks)." data-id="CD011681-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 SSRIs or SNRIs versus placebo, Outcome 2 Symptomatic/analgesic medication use (doses/month) (follow‐up: 8 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SSRIs or SNRIs versus placebo, Outcome 3 Headache index (follow‐up: 8 weeks)." data-id="CD011681-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 SSRIs or SNRIs versus placebo, Outcome 3 Headache index (follow‐up: 8 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SSRIs or SNRIs versus placebo, Outcome 4 Withdrawals ‐ any reason (follow‐up: 8 weeks)." data-id="CD011681-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 SSRIs or SNRIs versus placebo, Outcome 4 Withdrawals ‐ any reason (follow‐up: 8 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SSRIs or SNRIs versus placebo, Outcome 5 Withdrawals due to adverse events (follow‐up: 8 weeks)." data-id="CD011681-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 SSRIs or SNRIs versus placebo, Outcome 5 Withdrawals due to adverse events (follow‐up: 8 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SSRIs or SNRIs versus placebo, Outcome 6 Number of patients with minor adverse events (follow‐up: 8 weeks)." data-id="CD011681-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 SSRIs or SNRIs versus placebo, Outcome 6 Number of patients with minor adverse events (follow‐up: 8 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 1 Headache frequency (number of headache days)." data-id="CD011681-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 1 Headache frequency (number of headache days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 2 Headache intensity." data-id="CD011681-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 2 Headache intensity.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 3 Headache duration (hours/day)." data-id="CD011681-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 3 Headache duration (hours/day). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 4 Symptomatic/analgesic medications use (doses/4 weeks)." data-id="CD011681-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 4 Symptomatic/analgesic medications use (doses/4 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 5 Headache index." data-id="CD011681-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 5 Headache index.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 6 Withdrawals ‐ any reason." data-id="CD011681-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 6 Withdrawals ‐ any reason. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011681-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/urn:x-wiley:14651858:media:CD011681:CD011681-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_t/tCD011681-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 7 Withdrawals due to adverse events." data-id="CD011681-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 SSRIs or SNRIs versus other antidepressants, Outcome 7 Withdrawals due to adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011681/media/CDSR/CD011681/image_n/nCD011681-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011681-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">SSRIs or SNRIs versus placebo for tension‐type headache</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SSRIs or SNRIs compared to placebo for tension‐type headache</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with tension‐type headache<br/> <b>Intervention:</b> SSRIs or SNRIs<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SSRIs or SNRIs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache frequency</b><br/> (number of days with headache) </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache frequency ranged across control groups from<br/> <b>13.8 to 21.7 days with headache</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache frequency in the intervention groups was<br/> <b>0.96 lower</b><br/> (3.95 lower to 2.03 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>127<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> l<b>ow<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache intensity</b><br/> (score) </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache severity in the control groups was<br/> <b>3.9</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache severity in the intervention groups was<br/> <b>0.30 lower</b><br/> (1.13 lower to 0.53 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache duration</b><br/> (hours) </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache duration in the control groups was<br/> <b>6.57</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache duration in the intervention groups was<br/> <b>0.07 lower</b><br/> (2.69 lower to 2.55 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic/analgesic medication for acute headache attacks</b> <br/> (doses/month) </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean symptomatic/analgesic medication for acute headache attacks ranged across control groups from<br/> <b>1.07 to 34.8 doses</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean symptomatic/analgesic medication for acute headache attacks in the intervention groups was<br/> <b>1.87 lower</b><br/> (2.09 to 1.65 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This finding is largely driven by the results reported by a study at high risk of sponsorship bias </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache index</b> </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache index ranged across control groups from<br/> <b>18.3 to 877</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache index in the intervention groups was <b>0.24 SDs lower</b><br/> (0.59 lower to 0.11 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>128<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>As a rule of thumb, 0.2 SDs represents a small difference, 0.5 moderate and 0.8 large (<a href="./references#CD011681-bbs2-0034" title="CohenJ . Statistical Power Analysis in the Behavioral Sciences. 2nd Edition. New Jersey: Hillsdale: Lawrence Erlbaum Associates, Inc, 1988. ">Cohen 1988</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>OR 3.72</b> <br/> (0.79 to 17.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>190<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b><br/> (9 to 163) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI</b> : Confidence interval; <b>OR</b> : Odds ratio; <b>SD</b> : Standard deviation; <b>SNRI</b> : Serotonin‐norepinephrine reuptake inhibitor; <b>SSRI</b>: selective serotonin reuptake inhibitor </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Limitations in study design, imprecision (insufficient data).<br/> <sup>2</sup> Limitations in study design, imprecision (insufficient data), indirectness (lack of generalisability).<br/> <sup>3</sup> Limitations in study design, imprecision (insufficient data), inconsistency (heterogeneity). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">SSRIs or SNRIs versus placebo for tension‐type headache</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011681-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">SSRIs or SNRIs versus other antidepressants for tension‐type headache</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SSRIs or SNRIs compared to other antidepressants for tension‐type headache</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with tension‐type headache<br/> <b>Intervention:</b> SSRIs or SNRIs<br/> <b>Comparison:</b> other antidepressants </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Other antidepressants</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SSRIs or SNRIs </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache frequency</b> <br/> (number of days with headache) </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache frequency ranged across control groups from<br/> 14<b>.4 to 18.6 days with headache</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache frequency in the intervention groups was<br/> 0.76<b>higher</b><br/> (2.05 lower to 3.57 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two additional studies (<a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>) evaluated this outcome but were not pooled due to the lack of quantitative data </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache intensity</b><br/> (mean score) </p> <p>Follow‐up: 2 to 4 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache severity score ranged across control groups from<br/> 3.0<b>to 3.8</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache severity score in the intervention groups was<br/> <b>0.32 higher</b><br/> (0.55 lower to 1.19 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Four additional studies (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>; <a href="./references#CD011681-bbs2-0004" title="MannaV , BolinoF , DiCiccoL . Chronic tension‐type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache1994;34(1):44‐9. ">Manna 1994</a>; <a href="./references#CD011681-bbs2-0005" title="OguzhanogluA , SahinerT , KurtT , AkalinO . Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension‐type headaches. Cephalalgia1999;19(5):531‐2. ">Oguzhanoglu 1999</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>) evaluated this outcome but were not pooled due to the lack of quantitative data </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache duration</b> <br/> (hours) </p> <p>Follow‐up: 2 to 4 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache duration ranged across control groups from<br/> <b>5.39 to 6.5</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache duration in the intervention groups was<br/> 1<b>.26 higher</b><br/> (0.06 lower to 2.45 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>low<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic/analgesic medication for acute headache attacks</b> <br/> (doses/4 weeks) </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean symptomatic/analgesic medication for acute headache attacks ranged across control groups from<br/> <b>18.9 to 25.3 doses</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean symptomatic/analgesic medication for acute headache attacks in the intervention groups was<br/> <b>4.98 higher</b><br/> (1.12 lower to 8.84 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two additional studies (<a href="./references#CD011681-bbs2-0003" title="LangemarkM , OlesenJ . Sulpiride and paroxetine in the treatment of chronic tension‐type headache. An explanatory double‐blind trial. Headache1994;34(1):20‐4. ">Langemark 1993</a>; <a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>) evaluated this outcome but were not pooled due to the lack of quantitative data </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Headache index</b> </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache index ranged across control groups from<br/> <b>11.4 to 616</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean headache index in the intervention groups was<br/> <b>0.42 SDs higher</b><br/> (0 to 0.85 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>As a rule of thumb, 0.2 SDs represents a small difference, 0.5 moderate and 0.8 large (<a href="./references#CD011681-bbs2-0034" title="CohenJ . Statistical Power Analysis in the Behavioral Sciences. 2nd Edition. New Jersey: Hillsdale: Lawrence Erlbaum Associates, Inc, 1988. ">Cohen 1988</a>) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One study (<a href="./references#CD011681-bbs2-0007" title="WalkerZ , WalkerRWH , RobertsonMM , StansfeldS . Antidepressant treatment of chronic tension‐type headache: a comparison between fluoxetine and desipramine. Headache1998;38(7):523‐8. ">Walker 1997</a>) reported qualitative results on this outcome </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> <p>Follow‐up: 2 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>OR 1.04</b> <br/> (0.41 to 2.60) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>257<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>88 per 1000</b><br/> (37 to 194) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio; <b>SD</b> : Standard deviation; <b>SNRI</b> : Serotonin‐norepinephrine reuptake inhibitor; <b>SSRI</b>: selective serotonin reuptake inhibitor </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Limitations in study design, imprecision (insufficient data), inconsistency (heterogeneity).<br/> <sup>2</sup> Limitations in study design, imprecision (insufficient data).<br/> <sup>3</sup> Limitations in study design, imprecision (insufficient data), indirectness (lack of generalisability). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">SSRIs or SNRIs versus other antidepressants for tension‐type headache</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011681/full#CD011681-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011681-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">SSRIs or SNRIs versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Headache frequency (number of headache days) (follow‐up: 8 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.96 [‐3.95, 2.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 SSRI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐3.94, 3.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 SNRI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.30 [‐7.27, 2.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Symptomatic/analgesic medication use (doses/month) (follow‐up: 8 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.87 [‐2.09, ‐1.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 SSRI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.87 [‐2.09, ‐1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Headache index (follow‐up: 8 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐0.59, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 SSRI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.59, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 SNRI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐0.90, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Withdrawals ‐ any reason (follow‐up: 8 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.25, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 SSRI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.19, 1.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 SNRI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.17, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Withdrawals due to adverse events (follow‐up: 8 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.72 [0.79, 17.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 SSRI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.00, 6.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 SNRI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.88 [1.27, 37.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Number of patients with minor adverse events (follow‐up: 8 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.52, 4.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 SSRI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.40, 2.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 SNRI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.19 [0.78, 13.10]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">SSRIs or SNRIs versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011681-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SSRIs or SNRIs versus other antidepressants</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Headache frequency (number of headache days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Follow‐up: 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [‐2.05, 3.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Follow‐up: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [‐1.29, 2.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Headache intensity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Follow‐up: 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [‐0.55, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Follow‐up: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [1.06, 2.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Headache duration (hours/day) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Follow‐up: 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.06, 2.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Follow‐up: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐0.39, 2.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Symptomatic/analgesic medications use (doses/4 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Follow‐up: 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.98 [1.12, 8.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Follow‐up: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.40 [1.10, 9.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Headache index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Follow‐up: 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [‐0.00, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Follow‐up: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.08, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Withdrawals ‐ any reason <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [0.71, 3.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Withdrawals due to adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.41, 2.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SSRIs or SNRIs versus other antidepressants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011681/references#CD011681-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011681&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011681-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011681-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD011681-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ru#CD011681-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011681-note-0007">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011681\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011681\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011681\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011681"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011681\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011681\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011681\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011681\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011681\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011681"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011681\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011681\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011681\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011681"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011681\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011681\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011681\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011681"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WbpyPs9C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011681&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011681';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011681/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011681/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011681%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725066145"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011681/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725066149"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011681/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e722a2f7a1bdf',t:'MTc0MDcyNTA2Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 